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Abstract 
Aimetti, Alex A. (Ph.D., Chemical and Biological Engineering) 
Synthetic peptide design for functionalized hydrogels: Development of cellularly responsive 
drug delivery platforms and cyclic, multivalent peptide derivatives using radical-mediated thiol-
ene/thiol-yne chemistries. 
 
Thesis directed by Professor Kristi S. Anseth, Ph.D. 
 
Poly(ethylene glycol) (PEG)-based hydrogels represent a class of biomaterials with a 
growing interest for their application in numerous fields, such as drug delivery and regenerative 
medicine.  PEG is commonly used in these applications due to its hydrophilic and bioinert 
properties.  Additionally, peptides have been successfully incorporated within PEG hydrogels to 
serve as biological functionalities within a synthetic polymer platform.  Peptide-functionalized 
PEG hydrogels have been shown to act as extracellular matrix (ECM)-mimics capable of 
enhancing cell survival, function, and differentiation.  Alternatively, peptides can be designed to 
degrade in recognition of highly specific, cell-secreted proteases.  This phenomenon has been 
exploited for the fabrication of peptide-functionalized “smart” hydrogels, capable of undergoing 
macroscopic property changes in response to cellular events.  The goal of this thesis work was to 
design functional peptide sequences and control their presentation within PEG hydrogels for 
various biological applications.   
Specifically, two unique therapeutic delivery platforms containing covalently 
incorporated human neutrophil elastase (HNE) sensitive peptides were designed.  First, 
substrates were engineered with amino acid point mutations ultimately resulting in 
enzymatically-controlled degradation kinetics of varying rates.  These peptides were 
photopolymerized within PEG hydrogels as pendant functionalities, and their subsequent release 
was only observed in the presence of enzyme.  The rate of release was ultimately dictated by 
 iv 
environmental factors (e.g., [enzyme]) and substrate design (e.g., kcat).  Next, HNE-sensitive 
peptides were incorporated as functional crosslinks within PEG-based hydrogels using thiol-ene 
photopolymerization.  Protein therapeutics were included in the pre-cursor solution and 
physically entrapped upon gel formation.  The peptide crosslinks render the gel degradable and 
allow for protein release upon exposure to HNE.  The rate of gel degradation and subsequent 
protein release was influenced by gel formulation, enzyme concentration, and substrate design.  
Finally, cyclic, multivalent peptides were designed and synthesized using sequential 
thiol-ene/thiol-yne chemistries, exploiting the versatility of these radical-mediated 
photoreactions.  Results demonstrate that these novel synthetic routes provide a robust and 
efficient method to form complex peptide architectures that better mimic protein structure.  
Collectively, this thesis provides insight related to peptide design and subsequent use within 
synthetic hydrogels for various biological applications, especially those related to drug delivery 
and regenerative medicine. 
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1. Chapter 1 
Introduction 
 
1.1 Overview 
The field of polymeric biomaterials, especially hydrogels, has expanded dramatically in 
recent decades.  These biocompatible materials are used in a variety of applications ranging from 
drug delivery to regenerative medicine.  However, recent trends in biomaterials research 
demonstrate how homogeneous hydrogel systems are becoming incapable of addressing more 
complex clinical needs.  Instead, multi-component and multi-functional hydrogel materials are 
often necessary to form bioactive systems that can respond or adapt to various environmental 
conditions or provide specific cellular cues.  These so called smart materials or bioinspired 
materials are of growing importance, and this thesis focuses on aspects related to cellularly 
responsive hydrogel biomaterials.  
 Amongst the synthetic hydrogel biomaterial platforms, poly(ethylene glycol) (PEG) has 
been used extensively due to its long history of application in human medicine and its 
biologically inert properties.
1,2
   However, recent interest has focused on the development of 
functionalized biomimetic materials based on PEG that are not only biocompatible, but also have 
the ability to direct cellular function and/or respond to cellular stimuli.  To achieve this 
functionality, the incorporation of peptides within synthetic polymer networks has been shown to 
influence cell behavior
5
 and migration.
6
 Peptides are versatile biological moieties that can be 
utilized in a wide range of applications.  In particular, this thesis focuses on the novel design of 
 2 
synthetic peptides for their covalent incorporation within PEG hydrogels with the targeted 
applications in cell-dictated therapeutic release and, ultimately, in controlling cellular behavior. 
1.2 Peptides: Versatile biological building blocks for materials development 
 Peptides are small biomolecules consisting of subunits called amino acids.  There are 20 
naturally occurring amino acids.  Each amino acid consists of an amine and carboxylic acid 
group, as well as an !-carbon with an R group (Figure 1.1a).  The R group defines the amino 
acid and varies considerably in its functionality (i.e., amide, amine, hydroxyl, carboxylic acid, 
phenyl, thiol, etc.).  A peptide is formed when amino acids are joined together in a sequential 
manner (Figure 1.1b).  Peptides contain the same building blocks as proteins (i.e., amino acids), 
which renders them candidates for functional mimics of these biomacromolecules.  A peptide is 
loosely defined as a molecule containing less than 50 amino acids; however, many smaller 
peptides are derived as fragments of whole proteins and exhibit similar biological activity. 
 
Figure 1.1 a.) General structure of an amino acid. b.) Peptide structure illustrating stepwise 
addition of various amino acids. 
 Peptides are naturally occurring biomolecules that are classified based on their function.  
These versatile molecules can act as hormones (possess endocrine functions), neuropeptides 
(neuronal signaling molecules), alkaloids (naturally derived molecules, typically from plants, 
with biological activity), antibiotics (molecules that kill or prevent growth of bacteria), toxins 
(poisonous molecules), and regulation peptides.  Classic examples of peptides that fall into any 
of these categories are bradykinin, endorphin, gramicidin, agatoxin, and carnosine.
7
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1.3 Synthesis of peptides – traditional methods and improvements 
Peptides can be formed in a variety of ways including, but not limited to, solution phase 
synthesis, solid phase synthesis, and recombinant methods.  Herein, synthetic strategies and 
recent improvements are highlighted. 
1.3.1 Solution phase peptide synthesis 
Considered the ‘classical’ approach to peptide synthesis, liquid phase synthesis was used 
almost exclusively up until 1963.
8
  Solution phase synthesis had been successfully employed for 
the production of hundreds of peptides.  In specific, oxytocin (H-c[CYIQNC]PLG-NH2) was the 
first peptide hormone to be synthesized, and this work was awarded the Nobel Prize in 
Chemistry in 1954.
9
  Also, human insulin was first chemically produced using this method.  
Today, solution phase synthesis is rarely used in a laboratory setting; however, this method is 
still utilized on the industrial scale for the production of short peptides (i.e., <9 mer).  In fact, an 
Abbott Labs peptide drug to treat cancer, ABT-510 (Ac-Sar-Gly-Val-D-allo-Ile-Thr-Nva-Ile-
Pro-ArgNHEt), is currently produced on the kilogram scale using solution phase synthesis.
10
  
The advantages of this techniques are the low cost of raw materials and unlimited capacity.  
However, the drawbacks relate to the multiple purification steps required, long cycle times, and 
decreased yield of the desired molecule. 
1.3.2 Solid phase peptide synthesis (SPPS) 
In 1963, Bruce Merrifield published a paper in the Journal of the American Chemical 
Society that redefined the field of peptide synthesis.
8
 He presented a novel method for the 
synthesis of a tetrapeptide built on a solid polymeric support.  This technique overcomes the 
inherent disadvantage of solution synthesis by utilizing filtering as a facile way to purify excess 
reagents or reaction byproducts from the solid support containing the growing peptide chain.  He 
 4 
later extended his vision to develop the first solid phase automated peptide synthesizer that 
allowed for fast, reproducible synthesis of various peptides.
11
 
 Initially, Merrifield presented the use of carbobenzoxy (Cbz) as the amino protecting 
group, which was deprotected using HBr/HOAc.  Since that time, there have been multiple 
advancements regarding the protecting groups used for solid phase synthesis and conditions used 
for subsequent deprotection.  Currently, the Fmoc/tBu strategy is employed most often due to the 
efficient deprotection reactions using mild reagents. Figure 1.2 illustrates the Fmoc/tBu strategy 
used for the stepwise synthesis of a growing peptide chain from a solid phase.  
 In specific, an Fmoc (fluorenylmethyloxycarbonyl) protected (!-amino group) amino 
acid is coupled to the polymeric support.  Fmoc is removed under basic conditions making it a 
suitable protecting group that can be utilized with acid labile orthogonal protecting groups on 
each amino acid side chain.  Following Fmoc removal, a second amino acid is coupled to the free 
amine.  Coupling protocols vary and range from forming a symmetric anhydride using a 
carbodiimide, or forming an activated carboxy group, most commonly an OBt ester.  This 
process of deprotecting and coupling is repeated until the desired peptide is formed.  The peptide 
is then cleaved from the solid support under the appropriate conditions, typically acidic.  During 
this step, the amino acid side chain protecting groups are removed as well.  Typical impurities 
that arise as a result of solid phase peptide synthesis are deletion sequences due to inefficient 
coupling or Fmoc deprotection.  
 5 
 
Figure 1.2 Fmoc/tBu strategy for solid phase peptide synthesis. Figure adapted from Chan & 
White.
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Advancements in SPPS: Protecting groups for on-resin peptide modification 
 Over the past four decades, significant advancements have been made in the field of solid 
phase peptide synthesis.  Researchers have presented improvements to coupling and deprotection 
protocols, as well as the composition of polymeric supports used.  However, only novel amino 
acid side chain protecting groups that allow for selective removal will be discussed herein.  As 
described above, side chain protecting groups are typically designed to be removed under the 
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same conditions used to cleave the peptide from the solid support.  However, researchers have 
developed orthogonal protecting groups that are labile under unique chemical stimuli that allow 
for site-specific, on-resin peptide modification.  Here, naturally occurring Fmoc protected amino 
acids with selectively removable side chain protecting groups that were utilized in this thesis will 
be discussed.   
Fmoc-Lys(Mtt)-OH 
The methyltrityl (Mtt) group was first used to protect the !-amino group on lysine in 
1995.
13
  This hyper acid-sensitive protecting group is removed without cleaving the peptide from 
the resin.  This building block is useful for the site-specific fluorophore labeling of peptides, as 
well as other amine modifications. 
Fmoc-Lys(Dde)-OH 
The 4,4-dimethyl-2,6-dioxocyclohex-1–ylidene (Dde) protecting group for the !-amino 
group on lysine was introduced in 1996 by Nash et al.
14
  Unlike the Mtt protecting group, Dde is 
base labile and typically removed with hydrazine.  The combination of Lys(Mtt) and Lys(Dde) is 
frequently used within the same peptide sequence for site selective conjugation of FRET 
fluorophore pairs. 
Fmoc-Cys(Mmt)-OH 
The monomethoxytrityl (Mmt) protecting group was presented by Barlos et al. for the 
protection of the sulfhydryl group on cysteine.
15
  The Mmt group is commonly removed under 
similar conditions as the Mtt group (mild acidic).  The application of this group has allowed for 
the on-resin modification of cysteine with many functional groups such as iodoacetamides, 
maleimides, or alkyl halides. 
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1.3.3 Synthesis of cyclic peptides 
Peptides possess the ability to be functional protein mimics.  Peptide fragments isolated 
from whole proteins can successfully bind to intended targets with similar strength, specificity, 
and sometimes function.  However, when smaller linear peptides are extracted and/or 
synthesized (either chemically or biologically), they lose vital structural information that is often 
present in proteins.  These unordered structures exhibit decreased in vivo circulation times (half-
lives) and decreased binding affinity, which has severely limited the field of peptide therapeutics.  
To address these shortcomings, researchers have utilized peptide cyclization to improve the 
properties exhibited by linear peptides.  Constraining a peptide to a cyclic form presents a 
molecule with a more ordered secondary structure capable of binding to its intended target at 
decreased effective concentrations, mainly attributed to lowering the entropic cost of binding.
16
  
Additionally, cyclic peptides are known to be more resistant to proteolytic degradation.
17,18
  This 
phenomenon is related to the additional energy required for the enzyme to unravel the ordered 
peptide to initiate degradation.
19
  Figure 1.3 illustrates examples of cyclic peptides that have been 
found in Nature or have been used as protein analogs for therapeutic applications. Figure 1.3a 
and Figure 1.3c shows bacitracin and polymyxin B which are cyclic peptide antibiotics that act 
on gram positive and gram negative cell walls, respectively.  Octreotide (Figure 1.3b), a 
somatostatin analog, has been used as a treatment for a variety of diseases including, but not 
limited to, acromegaly and chronic pancreatitis. Valinomycin (Figure 1.3d) is a naturally 
occurring peptide isolated from cells that is used to assist transport of potassium ions in 
biological systems.   
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Figure 1.3 Examples of cyclic peptides. a.) bacitracin b.) octreotide c.) polymyxin B d.) 
valinomycin 
 Due to the many advantages of cyclic peptides, researchers continue to explore new 
synthetic routes to allow for efficient peptide cyclization.  Cyclic peptides are currently formed 
via disulfide, amide, olefin, and C-C bonds, as well as the azide-alkyne cycloaddition reaction.  
As part of this thesis research, a new and versatile approach for cyclic peptide synthesis will be 
demonstrated, and to put this work in context, a detailed description of existing methods for 
cyclic peptide formation is described below. 
Disulfide formation 
 Considered the classic form of cyclization, the disulfide bridge is a common reaction 
choice due to the natural occurrence of this bond in native proteins through two cysteine 
residues.   This oxidation reaction has been performed both on-resin or in solution using air,
20,21
 
redox buffers,
22,23
 dimethylsulfoxide (DMSO),
24,25
 potassium ferricyanide (K3Fe(CN)6),
26,27
 
iodine,
28,29
 thallium (III) trifluoroacetate,
30,31
 and alkyltrichlorosilane-sulphoxide.
32,33
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conducted in solution are performed under dilute concentrations to promote intramolecular 
disulfide formation.   Long cyclization times and the reversibility of the reaction are inherent 
disadvantages of this technique.  
Amide (lactam) formation 
 The condensation reaction between an amine and a carboxylic acid results in amide 
formation.   When that amide is part of a larger macrocycle, it is termed a lactam.  Head-to-tail 
cyclization is another common way to form cyclic peptides.  These reactions have been 
performed in solution using a protected peptide in an organic solvent
34
, as well as using an 
extended native ligation technique.
35
  In addition, a head-to-side chain or side chain-to-side chain 
on-resin cyclization reaction can be performed by selectively deprotecting glutamic acid (Fmoc-
Glu(Dmab)-OH) and conjugating the free amine to the acid using standard peptide coupling 
chemistry.
36
  An advantage of this approach is that it utilizes naturally occurring amino acids, 
and the coupling conditions are identical to those used during peptide elongation.  However, 
extended reaction times remain a disadvantage of this method.  
Olefin metathesis reaction 
Grubbs et al. exploited the ring-closing metathesis (RCM) between two olefins catalyzed 
with a ruthenium complex catalyst (Grubbs catalyst) for peptide cyclization.
37
  This technique 
has been extended to form peptide macrocycles on resin during peptide stapling.
18,38,39
  Peptide 
stapling is the process where a macrocycle is formed between one amino acid and another either 
four (i, i+4) or seven (i, i+7) positions away.  This process stabilizes an !-helix conformation 
with the i+4 and i+7 positions corresponding to 1 and 2 full helical turns, respectively.  Due to 
the hydrophobic nature of the aliphatic ‘staple’, the resulting peptides have been found to 
penetrate the cellular lipid bilayer allowing these biomolecules to bind intracellular targets.  
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However, with increasing hydrophobicity comes the inherent disadvantage of limited peptide 
solubility. 
C-C bond formation 
 Researchers have utilized the Heck reaction to form carbon-carbon bond 
macrocyclization on resin.
40
  The Heck reaction is a chemical reaction between an unsaturated 
halide and an alkene in the presence of base and a palladium (Pd) catalyst.  However, use of this 
method requires extended reaction times and results in poor isolated yield.  More recently, Byk 
et al. reported an improvement to this approach by utilizing microwave irradiation to decrease 
reaction time.
41
  
Azide-alkyne cycloaddition 
 Barry Sharpless introduced the term “click chemistry” in 2001 as a classification for 
rapid, highly efficient, selective chemical reactions through heteroatom links.
42
  With these 
unique characteristics, this set of powerful reactions is a desirable selection for the production of 
constrained peptides.  The Cu(I)-catalyzed Huisgen azide-alkyne 1,3-dipolar cycloaddition 
(CuAAC) is perhaps the most widely used click reaction and has been employed for the 
cyclization of peptides.
43-46
  Researchers studied various reaction conditions on cyclization time, 
yield, and resulting purity.  Reports show this click reaction produces cyclic monomers, dimers, 
and trimers, and the product ratios can be controlled with reaction conditions.  Similar to 
disadvantages of previous methods, reaction times up to 72 hrs have been reported in literature.  
Cyclic peptides: continued need for robust formation techniques   
 Despite the fact that various methods have been presented in literature for the formation 
of cyclic peptides, researchers continue to explore novel techniques for the formation of these 
molecules.  Scientists aim to discover unique ways to synthesize cyclic peptides in a rapid and 
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efficient manner.  Additionally, there is increasing interest in the scientific community to 
investigate methods that allow the formation of peptides with functional groups for subsequent 
conjugation with polymers, including the incorporation within hydrogel platforms to enhance or 
direct cellular function. 
1.3.4 Synthesis of multivalent peptides 
Multivalent interactions are known to play a critical role in many biological processes.
47
  
These events are characterized by concurrent binding of multiple ligands of a single molecule to 
multiple receptors on another biological entity.  Polyvalent interactions are known to be stronger 
compared to monovalent binding events. Similarly, the synthesis of multivalent peptides can 
further enhance the interaction of individual ligands with their receptors. 
Synthesis of multivalent peptides 
 Multivalent peptides are biomolecules that present multiple copies of a single peptide 
epitope.  The synthesis and application of multivalent peptides were presented 20 years ago, and 
research has progressed to discover novel, efficient ligation techniques to form these molecules 
either on-resin or in solution. 
Multiple antigenic peptide (MAP) system 
 Tam et al. presented a convenient and versatile method to form peptide dendrimers.
48
  
This publication was the first time a multivalent peptide was synthesized, and the technique was 
initially used to form peptide antigens.  The method exploited the lysine amino acid (containing 
both an ! and "- amino groups) as a facile way to form polyvalent peptides where the valency is 
equal to 2
n
 (where n=number of lysine residues). Figure 1.4 shows the synthetic scheme for the 
formation of multiple antigenic peptides (MAPs).  Fmoc-Lys(Fmoc)-OH is initially coupled to 
the resin.  Upon Fmoc deprotection, two free amines are available for subsequent modification.  
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By repeating this process, a peptide dendrimer structure with multiple hierarchies is created.  
After the desired valency is obtained, the user then builds the peptide on the solid phase using 
standard peptide coupling protocols.  
 
 
 
 
 
Native chemical ligation  
 Native chemical ligation is commonly used to combine two unprotected peptide units to 
form a larger polypeptide.  It is an aqueous reaction between a thioester and an N-terminal 
cysteine residue in the presence of a catalyst.  van Baal et al. first reported the use of this 
reaction for multivalent peptide formation.
49
  This technique is presented as a chemoselective 
reaction that allows for site-specific modification of peptides containing natural amino acids. 
Azide-alkyne cycloaddition 
 Researchers have turned to click chemistry in attempts to utilize novel, robust reactions 
for the formation of multivalent peptides.  CuAAC has been used in recent reports to click azido 
containing peptides to a core molecule presenting multiple alkynes.
3,50,51
  Researchers reported 
increased yields that were highly dependent on the peptide structure that was being clustered.   
Synthesis of cyclic, multivalent peptides resulted in decreased yields relative to linear, 
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multivalent peptides and this phenomenon was attributed to the bulky size of the macrocycle. 
Figure 1.5 illustrates an example of a click-mediated synthesis of multivalent peptides. 
 
Figure 1.5 Synthesis of multivalent peptides using CuAAC click chemistry.  Adapted from 
Rijkers et al.
3
 
Multivalent peptides: persistent need to discover techniques for efficient formation  
 Methods to control the nanoscale presentation of biological epitopes are of increasing 
interest to chemists and biologists.  Multivalent peptides present a high density of ligands 
capable of binding multiple cellular receptors.  These molecules have many therapeutic 
applications to biological pathways that require multivalent binding events.  The concept of 
multivalent peptides was introduced only two decades ago, so the field is relatively young and 
researchers continue to look for reaction mechanisms that exhibit rapid reaction times and 
increased product yield in attempts to optimize the process of formation. 
1.4 Peptide-functionalized hydrogels 
Researchers are interested in the formation and development of functional hydrogels that 
capture aspects of naturally occurring processes between cells and their extracellular/tissue 
environment with applications ranging from regenerative medicine to drug delivery.  Hydrogels 
are 3-dimensional networks of macromolecules that are rendered insoluble by physical or 
chemical crosslinks.  These hydrophilic constructs are capable of absorbing >99% of their weight 
in water making them a desirable material for numerous biomedical applications.  Hydrogels are 
routinely fabricated from natural or synthetic polymers.  Natural polymers including, but not 
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limited to, hylauronic acid, collagen, chitosan, and agarose have been utilized for hydrogel 
construction.
52
  These materials are desirable because they contain many of the biochemical cues 
needed to support cellular function and survival.  However, it is often difficult to tailor many of 
the gels properties reproducibly (e.g., biochemical and biomechanical).  Conversely, synthetic 
polymers are also used extensively for the formation of hydrogels.   Due to the high control over 
the final polymer composition and functionality, the various hydrogel properties can be easily 
engineered towards a specific application.  However, the inherent disadvantage of utilizing 
synthetic polymers is their lack of biological moieties.  Although some of these materials provide 
an inert surface, it is important to integrate biochemical signals that can initiate and direct 
cellular behavior.  To combine the benefits of both synthetic and natural hydrogels, researchers 
have exploited various techniques to incorporate peptides within synthetic hydrogels.  Peptide-
functionalized hydrogels exhibit many of the same advantages of synthetic materials such as 
high control over the chemical and mechanical properties of the gel, but integrate the benefits of 
protein based materials by providing a mechanism for the controlled introduction of biological 
cues to promote desired cell function.  The following sections describe current techniques used 
to incorporate peptides within hydrogel constructs, as well as their emerging applications. 
1.4.1 Techniques to incorporate peptides within hydrogel matrices 
The most common methods to incorporate peptides within hydrogel platforms are 
presented herein.   
Acrylate/acrylamide formation for subsequent photopolymerization 
Many synthetic hydrogels are chemically crosslinked using photoinitiated chain 
polymerization techniques.
53
  In these materials, peptides that contain the same chain 
polymerizable functionality are desirable as reactive macromers that allow for facile 
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incorporation via copolymerization.  Due to the widespread use of acrylate photopolymerization 
for forming hydrogel biomaterials, peptides have been functionalized with acrylate or acrylamide 
groups to allow for co-polymerization.  Most commonly, a heterobifunctional macromolecule 
(e.g., acrylate-PEG-N-hydroxysuccinimide: Acryl-PEG-NHS) is used to modify free amino 
groups.  The resulting monomer presents the peptide as a pendant group within the hydrogel 
network (Figure 1.6a).  This technique has been utilized to incorporate adhesive peptides within 
nonadhesive PEG hydrogels to promote cellular attachment.
5
  Additionally, Acryl-PEG-NHS has 
been used to form peptide crosslinks within a PEG based hydrogel (Figure 1.6b).
54
  By designing 
the peptide to be sensitive to proteolytic degradation, cells are able to secrete enzymes that break 
down the hydrogel network allowing for migration and extracellular matrix (ECM) deposition, 
important properties for tissue engineering applications.   
 
Additionally, acrylamide functionalities have been added to protected peptides on the 
solid-phase using acrylic acid.
55
  This technique is advantageous due to the selective 
modification of a single free amine allowing the peptide sequence to contain lysine residues.  
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crosslinks within hydrogel co-polymerized with PEG-diacrylate.  PI = photoinitiator 
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Additionally, synthesis on the solid phase eases the purification process. Figure 1.7 illustrates the 
synthesis of acrylamide containing peptides. 
 
 
Reactive groups, such as various vinyl functionalities, provide distinct advantages when 
fabricating peptide-functionalized hydrogels.  When combined with light-mediated 
polymerizations, the user can control peptide presentation within the material in both space and 
time.  Despite their numerous advantages and early use in designing peptide-containing 
biomaterials, post-synthetic modification of the peptide is necessary to introduce 
acrylate/acrylamide functional groups, making the method both time consuming and expensive.  
Michael-type addition 
 More recently, researchers have developed methods to incorporate peptides within 
hydrogels that do not require post-synthetic modification.  The sulfhydryl group on cysteine 
residues has been successfully employed in various reaction schemes for the covalent 
conjugation of peptides within polymeric matrices.  Using the cysteine functionality, hydrogels 
are formed using step polymerizations as opposed to chain polymerizations.  Step 
polymerizations lead to more ideal network structures compared to chain polymerizations, and 
degradation is not limited to simply the network crosslinks. 
PeptideH2N
OH
O
Peptide Coupling 
Chemistry
PeptideN
H
O
Figure 1.7 Synthesis of acrylamide functionalized peptide using acrylic acid and standard 
peptide coupling chemistry. 
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 Hubbell and coworkers utilized a Michael-type reaction between a thiol (Michael donor) 
and a vinyl sulfone (Michael acceptor) group to form peptide-functionalized, PEG-based 
hydrogels.  The terminal hydroxyl groups of multi-arm PEG were modified with vinyl sulfone 
functional groups, and the thiol groups on native cysteine residues were exploited.  Under basic 
conditions, the thiolate anion becomes the active species in the Michael reaction.  The reaction 
kinetics increase with pH due to a higher concentration of active species (thiolate anion). Figure 
1.8 depicts the method for forming peptide-co-PEG hydrogels using a Michael reaction.  
Peptides can be incorporated as crosslinks or pendant groups depending on the number of thiols 
present in the peptide sequence. These hydrogel platforms have been utilized for the controlled 
release of BMP-2 to promote bone formation,
6,56
 as well as scaffolds to study and control stem 
cell differentiation.
57
  
 This method for peptide incorporation is advantageous since it exploits the sulfhydryl on 
naturally occurring cysteine residues eliminating the need to modify the peptide.  However, the 
base catalyzed reaction requires careful tuning for biocompatibility and does not allow the spatial 
and temporal reaction control associated with photopolymerizations. 
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Radical-mediated thiol-ene / thiol-acrylate photopolymerization 
 Building for the concepts demonstrated with hydrogels formed from the Michael addition 
reaction mechanims, researchers have exploited the thiol group on cysteine residues for the 
radical-mediated incorporation of peptides within hydrogel networks using 
photopolymerizations.  The thiol-ene photoreaction is a radical mediated, step-growth reaction 
between a sulfhydryl and alkene commonly performed in the presence of a photoinitiator (Figure 
1.9).  Upon irradiation with light, radical species are generated from photolysis of the initiator.  
These radicals are capable of abstracting a hydrogen from a thiol to form a thiyl radical.  The 
thiyl radical can add across a carbon-carbon double bond forming a carbon-centered radical, and 
with proper selection of the ‘ene’ functionality, will undergo a chain transfer event to form 
another thiyl radical.  This cycle is continued until the concentration of radical species or reactive 
groups are consumed.  Similar to the Michael-type reaction, bis-cysteine peptides are 
incorporated as crosslinks while mono-cysteine peptides are presented as pendant groups in the 
step-growth network.  Fairbanks et al. presented the first report of thiol-ene based hydrogels for 
Figure 1.8 Schematic for hydrogel formation using multi-arm PEG vinyl sulfone and cysteine 
containing peptides under basic conditions.  Bis-cysteine peptides are incorporated as crosslinks 
while mono-cysteine peptides are presented as pendant molecules within in the hydrogel.   
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cell encapsulation utilizing cysteine containing peptides.
58
  The resulting hydrogel network 
structure is similar to the one shown in Figure 1.8, but the critical advantage of this 
photoinitiated technique is that it affords the user spatial and temporal control of the reaction.  
 
Figure 1.9 Thiol-ene reaction mechanism. 
 As an alternative to the thiol-ene mechanism, thiol-acrylate mixed mode 
photopolymerizations have been utilized for the facile incorporated of cysteine containing 
peptides into PEG hydrogels.  Because of the nature of the acrylate functionality, this reaction 
mechanism involves both chain and step growth propagation steps.  Since acrylates can 
homopolymerize, chain growth occurs simultaneously with the thiol-acrylate step growth 
addition.   The chain transfer constant of acrylates with cysteine-containing peptide thiols was 
experimentally determined to vary between 1.5 – 2.  Further, the reactivity of the thiol group was 
found to be dependent on the adjacent amino acid.  Positively charged amino acids and amino 
acids capable of hydrogen bonding exhibited enhanced thiol reactivity while bulky amino acid 
side chains resulted in decreased reactivity.
59
  Arg-Gly-Asp and gluagon-like peptide-1 (GLP-1) 
have been incorporated within PEG hydrogels using the thiol-acrylate photopolymerization to 
study their dose-depending effect on human mesenchymal stem cell and islet viability, 
respectively.
60,61
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 These radical-mediated reactions between a thiol and vinyl group exhibit the combined 
advantages associated with acrylate photopolymerization (i.e., spatial and temporal control of 
initiation) and Michael-type addition (i.e., eliminates post-synthetic modification of the peptide).  
The stoichiometric, step-growth nature of the thiol-ene reaction results in a more homogenous 
network with the controlled presentation of peptide moieties. Conversely, the thiol-acrylate 
reaction creates heterogeneous networks where cysteine-containing peptides are present at the 
terminal ends of polyacrylate kinetic chains and can be incorporated at low concentrations. 
Azide-alkyne cycloaddition 
 More recently, peptides have been covalently conjugated within hydrogels using robust 
click reactions.  In specific, CuAAC has been utilized to incorporate enzyme-sensitive peptides 
as crosslinks within PEG gels, using this unique reaction mechanism to form hydrogels with 
final structures similar to those synthesized via Michael addition or thiol-ene reactions. 4-arm 
PEG-azide was combined with a bis-alkyne containing peptide in the presence of copper sulfate 
and sodium ascorbate to form the crosslinked network.  Gelation occurred within 4 minutes of 
mixing the components together.
62
  However, due to the toxic nature of the copper catalyst, this 
material has limited utility in biomaterials applications.  More recently, a Cu-free click reaction 
was utilized to form these peptide-functionalized hydrogels.  Difluorinated cyclooctyne (DIFO) 
spontaneously reacts with azides in the absence of a catalyst.  A bis-DIFO containing matrix 
metalloprotease (MMP)-sensitive peptide was added to a 4-arm PEG-azide to form a hydrogel 
(in the presence of cells) within 5 minutes.
63
 This strain-promoted azide-alkyne cycloaddition 
(SPAAC) has applications in a variety of biological areas. 
 The copper-free reaction provides a bioorthogonal reaction that can be utilized in 
combination with the orthogonal thiol-ene reaction to control the presentation of a variety of 
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peptides.  To date, this has been demonstrated by using alkyne-containing peptides to form the 
functional crosslinks of the hydrogel, while photoreactive alkene groups allow for controlled 
patterning of cysteine-containing peptides via the thiol-ene mechanism. 
Alternate methods for the fabrication of peptide-functionalized hydrogels 
 While the systems described above constitute the major of approaches pursued in the 
literature to date, native chemical ligation (NCL) provides another reaction mechanism that has 
been utilized for peptide incorporation within hydrogel platforms.  Su et al. demonstrated the 
enhanced survival of encapsulated MIN6 !-cells in gels formed using NCL when challenged 
with pro-inflammatory cytokines.  The gel was comprised of PEG, an anti-inflammatory peptide, 
and an adhesion peptide.
64
 
In addition to utilizing various chemical reactions to form covalently crosslinked, 
peptide-functionalized hydrogels, self-assembly has been exploited for the formation of 
hydrogels with peptide functionalities.  Peptides have the ability to self assemble into various 
nanostructures based on intermolecular macromolecular interactions.  Peptide fibers 
spontaneously form when hydrophilic peptide sequences are combined with hydrophobic, alkyl 
tails (Figure 1.10).  The resulting fibers physically crosslink to result in macroscopic hydrogel 
networks.  Gels formed by this method have been utilized for various biomedical applications 
including materials to promote bone formation
65
 and stem cell differentiation.
66
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Figure 1.10 Molecular schematic of peptide nanofiber formation via self assembly. Figure 
adapted from Hartgerink et al.
65
 
1.4.2 Peptide-functionalized hydrogels as stimuli responsive materials 
Beyond tuning initial material properties and biochemical functionality, peptides are 
capable of transforming a synthetic environment into an extracellular matrix mimic by the 
controlled presentation of these biomolecules.  Peptide-functionalized hydrogels are readily 
designed to respond to environmental stimuli, depending on the local cell population.  As such, 
these bioinspired and triggerable biomaterials have uses in a variety of wound healing, drug 
delivery, and tissue regeneration applications. 
Cellularly responsive drug delivery 
Many drug delivery systems are pre-engineered to release a therapeutic at a known rate, 
and while this can be advantageous, many diseases are complex and a priori knowledge of the 
optimal delivery rate, dose, and mechanism can be limited.  Thus, there is a need to develop 
delivery systems that can adapt to environmental conditions at the site of implantation or 
injection.  For example, many disease states are known to correlate with cellular upregulation of 
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various biomolecules including enzymes.  Peptides are substrates that are capable of being 
engineered for degradation by specific enzymes, and scientists have targeted these naturally 
occurring events to develop peptide-based materials that respond to specific and local stimuli.  
Enzymatic degradation is often exploited to cause a macroscopic change in material properties, 
ultimately resulting in controlled therapeutic release.  This technique has been used in a variety 
of systems that are discussed herein. 
Material degradation 
 Therapeutics, mostly globular proteins, can be physically entrapped within polymeric 
hydrogel networks.  Upon degradation of the matrix, molecules are released in a controlled 
manner, based on size-dependent diffusion characteristics.  Lutolf et al. encapsulated bone 
morphogenetic protein-2 (BMP-2) with a PEG-peptide hydrogel formed via the Michael-type 
reaction.  MMP-sensitive peptides were used as functional crosslinks within the network.  Upon 
exogenous delivery of MMP-2, BMP-2 was released whereas protein remained entrapped in the 
material in the absence of MMP-2.
4
 
 
 
 
 
 
Figure 1.11 Schematic illustrating enzyme responsive PEG-peptide hydrogel formation 
using a Michael-type addition and subsequent BMP-2 release in the presence of MMP-2. 
Green arrow ( ) corresponds to RGDS peptide ligand while red squares ( )indicate MMP 
sensitive peptide crosslink.  Figure adapted from Lutolf et al.
4
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Material swelling 
Further, researchers have developed PEG hydrogel particles that undergo an enzyme 
induced volumetric change that allows for subsequent release of an entrapped payload.  Thornton 
et al. synthesized an enzyme cleavable linker (ECL) on a solid-phase PEG microparticle.
67,68
  
The ECL was designed to contain oppositely charged amino acid residues adjacent to the enzyme 
degradation site, thus creating a zwitterionic peptide with no overall charge.  Upon enzyme-
mediated peptide degradation, a negatively charged carboxylic acid fragment was removed 
leaving behind a cationic amine tethered to the polymeric network.  The overall positive charge 
of the material causes the gel to swell and release entrapped protein therapeutics (Figure 1.12).  
The proteins are initially loaded in the material by altering the pH of the swelling medium.  At 
pH values below the pKa of the carboxylic acid functional group on aspartic acid, the hydrogel 
swells allowing diffusion in of the macromolecular payload. 
 
 
 
 
 
Figure 1.12 Mechanism for enzyme induced hydrogel swelling allowing for controlled 
protein release. 
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Pendant peptide/therapeutic release 
Enzyme cleavable peptides have also been included as pendant groups within hydrogel 
platforms.  Because hydrogels have a high water content, simple approaches to tuning diffusion 
controlled release can be limited and often require strategies to conjugate smaller molecules to 
extend their temporal release.  Various therapeutics, small molecules or proteins, have been 
covalently added to peptides allowing for controlled delivery as dictated by enzyme-mediated 
degradation events.  The rate of therapeutic release is then directly correlated to basic enzyme-
dictated reaction kinetics.  Additionally, one degradation event leads to the delivery of one 
therapeutic in a manner that is dictated by the local enzyme concentration.  Sakiyama-Elbert et 
al. utilized this technique for the delivery of ! nerve growth factor (!-NGF) from a fibrin matrix 
in response to elevated plasmin activity (Figure 1.13).
69
  An advantage of this approach is that 
the release profile can be precisely tuned by altering the peptide sequence, ultimately varying the 
rate of enzyme cleavage.  However, an inherent disadvantage to this technique is that covalent 
modification of a therapeutic is necessary potentially comprising the effectiveness.   
 
 
Figure 1.13 Design of a plasmin-mediated delivery system.  Human !-NGF is covalently 
attached to a degradable plasmin substrate tethered to a fibrin matrix.  Plasmin can degrade its 
respective substrate releasing !-NGF to the local environment.
69
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1.4.3 Alternative applications for the incorporation of cyclic, multivalent peptides 
Due to the ability of cyclic peptides to bind more strongly to various protein targets or 
integrins, they are incorporated within hydrogels for a variety of applications.  The tripeptide 
arginine-glycine-aspartic acid (RGD) is known as a cell-adhesive molecule that acts through a 
variety of integrins on the cell surface.  When incorporated on a surface or within a 3-
dimensional construct, RGD has been shown to enhance cell survival,
55,70
 spreading,
71
 
migration,
72
 and other cellular functions.  Cyclic RGD (cyclo(RGD)) has been integrated within 
hydrogels and various cellular responses have been monitored.  Wacker et al. conjugated cyclic 
and linear RGD to PEG hydrogels and studied the effects of endothelial cell migration in the 
presence of a chemokinetic agent.  The authors concluded that cyclic RGD containing hydrogels 
resulted in the fastest rate of cell migration and exhibited the highest initial cell adhesion to the 
gels.
73
   Zhu et al. examined endothelial cell adhesion, spreading and proliferation when seeded 
on PEG hydrogels containing cyclo(RGD).  Adhesion and spreading were enhanced and cellular 
population was increased 44% on cyclic RGD containing hydrogels relative to linear RGD.
74
  
Tsang et al. utilized photopolymerization techniques for incorporation of cyclic RGD to enhance 
the formation of hepatic tissue.
75
 
Additionally, clustering of signaling peptides has been shown to exhibit an effect on 
multiple cellular processes.  In specific, nanoscale clustering of RGD was found to influence cell 
adhesion strength,
76
 migration,
77
 cell spreading, proliferation, and osteogenic differentiation.
78
  
These bodies of work have provided compelling evidence that clustering critical peptides is 
important for applications in regenerative medicine.
79
 Alternatively, multivalent peptides have 
been incorporated within PEG hydrogels as interpenetrating networks for the affinity binding-
controlled release of bFGF.
80
  Lin et al. showed enhanced retention (prolonged release) of bFGF 
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from PEG hydrogels as compared to varying concentrations of monovalent peptide 
(KRTGQYKL).  
1.5 Thesis Approach 
This thesis aims to harness the versatility of synthetic peptides by developing new 
synthetic routes for the formation of cyclic and multivalent peptides, along with strategies for 
their integration and application within hydrogel platforms (Figure 1.14).  Specifically, this 
research focuses on exploiting photopolymerization mechanisms for the facile incorporation of 
peptides within PEG hydrogels, as well as strategies for controlling peptides primary and 
secondary structure via thiol-ene and thiol-yne reactions.  Peptides can be enzyme cleavable 
linkers, and when incorporated within hydrogels, the materials can be engineered to induce 
macroscopic material changes in response to proteolytic degradation.  Scientists can exploit this 
action to design novel “smart” materials capable of responding to the local biological 
environment.  Alternatively, peptides can be used as functional protein mimics.  These small 
biomolecules can selectively bind to targets and induce a desired cellular event.  This thesis 
focus on novel peptide design to control the rate of peptide cleavage via tunable enzyme kinetics, 
as well as enhancing the potency of receptor binding by controlling peptide presentation.  
Chapter 2 outlines the detailed objectives of this thesis work.   
With respect to tunable degradation, Chapter 3 presents the development of human 
neutrophil elastase (HNE) sensitive peptides incorporated within PEG hydrogel for cellularly 
responsive therapeutic delivery.  Amino acid point mutations in highly specific locations along 
the peptide were examined and the effects on the enzyme kinetics were quantified.  Further, a 
FRET-based HNE substrate was developed to visualize the spatial activity of the enzyme within 
the 3-dimensional hydrogel.  Lastly, tailorable HNE triggered released was demonstrated by 
 28 
varying the substrate or concentration of enzyme.  To complement this strategy, thiol-ene 
polymerization mechanisms were investigated to develop PEG hydrogels with HNE degradable 
crosslinks.  Chapter 4 presents the synthesis of bis-cysteine containing HNE substrates 
incorporated as functional crosslinks within hydrogel network.  The controlled release of 
entrapped protein therapeutics was characterized in the presence of HNE. 
Research efforts were then focused on utilizing photomediated reactions to control peptide 
structure with a goal of enhancing cellular interactions within hydrogels for 3-dimensional cell 
culture applications.  Chapters 5 and 6 focus on methods to enhance peptide-receptor binding.  In 
specific, Chapter 5 presents a novel method for on-resin peptide cyclization of an important cell 
adhesion sequence, RGD, using thiol-ene chemistry.  Chapter 6 then presents strategies to 
synthesize multivalent macromolecules containing RGD using thiol-yne chemistry.  Both of 
these strategies demonstrate completely new techniques for synthesizing and controlling peptide 
architecture using recent advances in polymerization synthesis.  Finally, Chapter 7 presents 
progress in evaluating the benefits of cyclic and/or multivalent peptide macromolecules 
incorporated within PEG hydrogel for directing critical cell function, as well as discusses the 
important implications for future avenues of inquiry towards novel peptide design related to 
biomaterials regulated drug delivery, 3D cell culture, and tissue regeneration. 
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Figure 1.14 Novel peptide design for incorporation within hydrogel platform thesis organization. 
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2. Chapter 2 
Objectives 
 
This thesis aims to exploit the versatility of peptides by exploring methods to 
synthesize functional sequences and then engineer their presentation within hydrogel 
platforms for various biological applications.  Peptide functionalized hydrogels have been 
used to enhance cellular survival and function, as well as act as a trigger that induces 
macroscopic changes in materials properties.  A special emphasis of this thesis is placed 
on the novel design of peptide sequences that are engineered to respond to cellular stimuli 
or to enhance integrin binding. 
In specific, we aim to develop two unique hydrogel drug delivery platforms 
through the covalent incorporation of enzyme cleavable peptides.  These hydrogels are 
designed to achieve cellularly responsive release in recognition of a highly specific 
enzyme.  Human neutrophil elastase (HNE) was chosen as the targeting enzyme.  HNE is 
a unique protease that is up-regulated at sites of inflammation.  Inflammation is a 
debilitating condition that has been implicated in many disease states and is often 
associated with biomaterial implantation.  During this biological response, immune cells 
migrate to the site and attempt to combat the foreign material.  Neutrophils are the first 
responding cells to these microenvironments.  Once activated, these inflammatory cells 
degranulate and release a variety of biomolecules including HNE.  Since biomedical 
implants, including cell-laden hydrogels, initiate an inflammatory cascade, we 
hypothesize that the incorporation of HNE-sensitive substrates within these materials can 
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act as a cue for local and cellularly dictated therapeutic release.  We further predict that 
the kinetics of enzyme triggered therapeutic release can be influenced by substrate design 
(varying kcat), local concentration of the targeted enzyme, and hydrogel design 
(concentration of substrate and/or crosslink density).   
Peptides can also act as extracellular matrix (ECM) mimics capable of influencing 
cell function; however, peptides derived from larger biomolecules often exhibit inherent 
disadvantages, such as decreased efficacy and half-life, compared to the native ECM 
component.  Taking a chemical biology approach to peptide design, small biomolecules 
can be engineered to act as more potent ECM mimics and allow for greater control and 
influence over cell function and behavior.  Arginine-glycine-aspartic acid (Arg-Gly-Asp; 
RGD) is a well-studied tripeptide derived from the adhesion protein fibronectin.  This 
peptide is capable of binding multiple cell-surface receptors and has been implicated as a 
therapeutic for a variety of diseases including, but not limited to, thrombosis and cancer.
1
  
Further, it has been incorporated within hydrogel platforms to promote cell attachment, 
migration, survival, function, etc.
2
  Researchers have demonstrated enhanced effects of 
RGD by controlling the conformation (cyclic peptide formation) and presentation 
(multivalent peptide formation) using various chemical reactions.  Herein, we 
hypothesize that radical-mediated click reactions, previously used for hydrogel 
fabrication, will serve as a rapid and efficient method for producing cyclic, multivalent 
peptides.  RGD is presented as a model peptide to demonstrate proof of concept 
regarding the method of controlling peptide structure.  Since RGD is such a well-
documented peptide in literature, it provides a benchmark from which to compare our 
peptide derivatives.   
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To demonstrate our overall goal of exploiting the versatility of synthetic peptides 
and their various applications within hydrogel platforms, the specific objectives of this 
thesis are as follows:  
 
I.) Design and characterize cellularly cleavable peptides capable of achieving 
highly controlled, predictable release when incorporated within poly(ethylene 
glycol) hydrogels. 
Inherent to this objective are a wide range of analytical and biological 
characterization techniques to evaluate engineered peptides.  Amino acid point mutations 
can be incorporated in highly specific locations within substrates and the kinetics of 
enzyme-mediated degradation subsequently characterized.  High-pressure liquid 
chromatography (HPLC) and matrix-assisted laser desorption ionization mass 
spectrometry (MALDI-MS) allow confirmation of peptide identity.  A solution phase 
enzyme assay enables quantification of Michaelis-Menten kinetic constants.  Peptides 
functionalized with acrylate groups allow subsequent incorporation within PEG 
hydrogels.  Additionally, a Förster resonance energy transfer (FRET) based substrate 
allows visualization of the spatial distribution of the enzyme within macroscopic PEG 
hydrogel.  Lastly, enzyme-triggered, controlled, predictable release is demonstrated from 
PEG hydrogels by varying the substrate.  
 
II.) Develop and evaluate a poly(ethylene glycol)-based hydrogel formed via 
thiol-ene photopolymerization containing enzyme cleavable peptides designed as 
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functional crosslinks and degradation-mediated release of entrapped protein 
therapeutics. 
This objective involves exploiting the thiol-ene photopolymerization reaction 
scheme as a facile method to incorporate peptides within PEG-based hydrogels.  4-arm 
PEGs functionalized with alkenes react with bis-cysteine containing substrates to form an 
ideal, step-growth network.  Protein therapeutics added to the prepolymer solution 
become physically entrapped within the crosslinked network upon gel formation.  
Substrates designed in the previous objective can be used to form a degradable network 
upon the addition of enzyme.  Hydrogel mass loss studies provide insight into the 
mechanism and control of the kinetics of gel degradation.  Additionally, the bioactivity of 
the release protein can be evaluated to confirm that the thiol-ene reaction does not lead to 
deleterious effects on the efficacy of the protein.  Lastly, multi-layered hydrogel formed 
by sequential photopolymerizations provide a means to fabricate complex drug delivery 
devices capable of achieving a predictable bimodal release profile and/or tailoring the 
release of multiple proteins. 
 
III.) Synthesize and characterize cyclic, multivalent peptides using sequential 
thiol-ene/thiol-yne photoreactions to enhance peptide binding.  Evaluate the effects 
of cyclic, multivalent RGD on cell function within a 3-dimensonal hydrogel.   
The peptide RGD provides a model system to demonstrate proof of concept that 
the thiol-ene radical-mediated reaction allows for an efficient and rapid method for cyclic 
peptide formation.  The reaction is evaluated on-resin and in solution using both photo 
and thermal initiation schemes.  To confirm unambiguously the identity of the product, 
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various analytical characterization techniques are employed, including HPLC, MALDI, 
NMR (
1
H, 
13
C, COSY, NOESY, HSQC, HMBC).  Enzyme linked immunosorbent assays 
(ELISA) confirm the formation of cyclic peptides via the thiol-ene reaction, as well as 
retention of therapeutic activity.  In this regard, IC50 values allow quantification of the 
potency of the formed product. 
This approach can be extended by use of radical-mediated thiol-yne reactions, 
providing a facile method for multivalent peptide formation.  Again, RGD provides a 
model system to illustrate proof of concept.  Through peptide design, the thiol-ene 
reaction allows creation of cyclic peptides on-resin, while a free thiol remains available 
for subsequent thiol-yne photoreaction.  The thiol-yne reaction is also evaluated as a 
method for forming both cyclic and linear multivalent peptides.  HPLC, MALDI, and 
SDS-PAGE are used to characterize the formed products, and a competitive binding 
ELISA is used to evaluate the effect of clustered RGD as an inhibitor of fibrinogen 
binding to glycoprotein IIb/IIIa. 
Lastly, initial studies were performed to evaluate the effects of cyclic, multivalent 
RGD formed using sequential thiol-ene/thiol-yne photoreaction on cell viability in 3-
dimensional PEG hydrogel.  
 
Collectivity, the objectives of this thesis are intended to highlight novel ways to 
exploit the versatility of peptides for the fabrication of hydrogel drug delivery platforms 
and the synthesis of cyclic, multivalent peptides both using photo-mediated chemical 
reactions. 
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3. Chapter 3 
Human neutrophil elastase responsive delivery from poly(ethylene glycol) hydrogels 
Manuscript appearing in Biomacromolecules, 10 (6), 1484-1489 (2009). 
 
3.1. Abstract 
A novel enzyme-responsive hydrogel drug delivery system was developed with the 
potential to treat inflammation locally.  Human neutrophil elastase (HNE) is a serine protease 
secreted by neutrophils which are the first cells recruited to inflammatory sites.  We exploited 
this cell-secreted enzyme as a biological cue for controlled release.  HNE sensitive peptide 
linkers were immobilized within poly(ethylene glycol) hydrogels using photopolymerization 
techniques.  The kinetics of the enzyme reaction within the gel was tailored by varying the amino 
acid residues present in the P1 and P1’ substrate positions (immediately adjacent to cleavage 
location).  A novel FRET-based hydrogel platform was designed to characterize the accessibility 
of the substrate within the crosslinked, macroscopic hydrogel.  Lastly, a diffusion-reaction 
mathematical model with Michaelis-Menten kinetics was developed to predict the overall release 
profile and captured the initial 80% of the experimentally observed release.  The hydrogel 
platform presented shows highly controlled release kinetics with potential applications in cellular 
responsive drug delivery. 
3.2. Introduction 
A major goal in drug delivery is to control spatially and temporally the release of 
therapeutics in vivo.  Localized and sustained drug delivery has the potential to enhance the 
therapeutic efficacy of treatment by minimizing systemic drug concentrations and the need for 
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repeated drug administration.
1
  More recently, efforts have been made to fabricate intelligent 
drug delivery systems that release therapeutics in response to physical or biological stimuli, such 
as temperature,
2,3
 pH,
4-6
 glucose,
7,8
 or enzymes.
9-11
  While these systems have provided great 
advancements in the area of controlled release, there remains a need for biomaterials to respond 
and adapt to cellular stimuli in the areas of drug delivery and tissue regeneration. 
An emerging area of drug delivery focuses on localized, controlled release in recognition 
of a cellular response.  For example, human bone morphogenetic protein-2 (BMP-2) has been 
entrapped within a 4-arm poly(ethylene glycol) (PEG) hydrogel crosslinked with matrix 
metalloproteinases (MMPs) sensitive peptides.  Once implanted at defect sites in rat calvaria, 
cell-secreted MMPs were able to degrade the gel and liberate the encapsulated BMP-2, which 
promoted cell infiltration and led to remodeling of bony tissue.
12
  In another approach, vascular 
endothelial growth factor (VEGF) was covalently attached to fibrin gels through thrombin 
cleavable substrates for wound healing applications.
13
 
A similar approach can be taken to develop enzyme responsive biomaterials to achieve 
local drug delivery at sites of inflammation.  Inflammation has been implicated in wound healing 
and many diseases such as diabetes,
14
 rheumatoid arthritis,
15
 and cancer.
16
  During this biological 
response, immune cells infiltrate the site of infection/injury and secrete a variety of biomolecules 
in a protective attempt to remove the harmful stimuli.  In specific, neutrophils are the first 
responding cells to these microenvironments.
17
  Upon activation, neutrophils degranulate and 
release a variety of enzymes such as human neutrophil elastase (HNE).  An elevated presence of 
this enzyme implies a highly specific biological event (disease or injury) is occurring, thus 
making HNE a desirable triggering molecule for local therapeutic delivery.
18
  This serine 
protease has a specificity for small, uncharged amino acids, particularly alanine (A) and valine 
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(V).
19
  Synthetic peptides containing the sequence Ala-Ala-Pro-Val have been studied as HNE 
specific substrates
20
 for drug delivery applications.
21
  By incorporating a similar elastase 
sensitive peptide into a biomaterial, an increased local concentration of HNE at sites of 
degranulation can be used as a cellular cue to release an anti-inflammatory therapeutic. 
In this contribution, we present and characterize a drug delivery platform with the 
potential to achieve HNE-triggered, controlled, and localized drug release from PEG hydrogels.  
Specifically, HNE-sensitive linkers were photopolymerized into PEG diacrylate (PEGDA) 
hydrogels as pendent groups as seen in Figure 3.1.  Upon the onset of an inflammatory response, 
HNE diffuses into the PEG hydrogels and cleaves its respective substrate liberating a therapeutic 
to the local environment.  Research has shown that the amino acid positions directly adjacent to 
enzyme cleavage location (P1 and P1’) are important for varying proteolytic reaction rates.
22,23
   
This work examines the effect of point variations within the elastase substrate at specified 
locations on the cleavage kinetics and exploits these differences to obtain varying release profiles 
from the hydrogel.  In addition, a Förster resonance energy transfer (FRET)-based hydrogel was 
developed to characterize the accessibility of the substrate to the enzyme within a crosslinked 
polymer network.  Lastly, a diffusion-reaction model, taking into account both molecular 
diffusion and Michaelis-Menten kinetics, was developed to better understand the mechanisms 
dominating release from the HNE-responsive hydrogels. 
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Figure 3.1 Schematic representation of photopolymerization of PEGDA with an acrylated HNE 
sensitive substrate. 
 
3.3. Experimental Section 
Materials 
Poly(ethylene glycol) (PEG, Mn~10,000) was obtained from Aldrich (St. Louis, MO 
USA). Monoacrylate-PEG-N-hydroxysuccinimide (APEG-NHS, Mn~3,400) was purchased 
from Laysan Bio, Inc (Arab, AL USA). Fmoc protected amino acids in their L-configuration as 
well as O-Benzotriazole-N,N,N’,N’-tetramethyl-uronium-hexafluoro-phosphate (HBTU), 1-
hydroxybenzotriazole hydrate (HOBt), and 2-(1H-7-Azabenzotriazol-1-yl)--1,1,3,3-tetramethyl 
uronium hexafluorophosphate methanaminium (HATU) used for amino acid activation were 
obtained from Anaspec (San Jose, CA USA).  MBHA Rink Amide resin was purchased from 
Novabiochem (La Jolla, CA USA). 5(6)-carboxyrhodamine (ROX) and QXL™ 610 acid (QXL) 
were obtained from Anaspec.  Fluorescamine was provided by Sigma-Aldrich (St. Louis, MO 
!
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USA).  Human neutrophil elastase (HNE) was supplied as a lyophilized powder from Innovative 
Research (Arab, AL USA). 
Poly(ethylene glycol) diacrylate (PEGDA10k) synthesis  
Linear PEGDA10k was synthesized similar to reported literature
24
 by reacting PEG 
(Mn~10,000) with a 8 molar excess of acryloyl chloride in the presence of triethyleamine (TEA).  
The reaction was allowed to proceed overnight at room temperature protected from light.  The 
acrylated PEG was filtered through a bed of alumina to remove the TEA-HCl complex.  Toluene 
was then removed from the reaction mixture under rotary evaporation.  To obtain pure 
PEGDA10k, the crude product was dissolved in methylene chloride and precipitated in cold 
diethyl ether.  The purified product was then filtered and dried in vacuo at room temperature.  
The degree of acrylation was confirmed to be >90% by 
1
H NMR (Supporting Information). 
Peptide synthesis  
Peptide sequences (Table 3.1) were synthesized (Applied Biosystem 433A Peptide 
Synthesizer) using solid phase Fmoc chemistry on a MHBA Rink Amide Resin (~0.7 mmol g
-1
 
resin substitution).  Peptides were cleaved from their solid support using trifluoroacetic acid 
(TFA)/triisopropylsilane (TIS)/water (95/2.5/2.5 v/v) and allowed to react at room temperature 
for 2h.  The reaction was filtered and the filtrate precipitated and washed (3x) in chilled diethyl 
ether.  Peptides were purified by semi-preparative reversed phase HPLC (Waters Delta Prep 
4000) using a 70-min linear (5-95%) gradient of acetonitrile in 0.1% trifluoroacetic acid.  Peptide 
purity was confirmed by analytical reversed phase HPLC C18 column and matrix-assisted laser 
desorption ionization time-of-flight mass spectrometry (Applied Biosystem DE Voyager).    
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Table 3.1 HNE sensitive peptides synthesized showing point variations in the P1 and P1’ 
positions.  Arrow indicates cleavage location. Unless otherwise noted, the default amino acid for 
the P1 position was Val and Gly for the P1’ position.  Non-native amino acid abbreviations 
represent Abu=aminobutyric acid, Nva=norvaline, Nle=norleucine. 
 
Kinetic analysis of substrate degradation  
Degradation kinetic parameters were determined using a fluorescamine fluorometric 
assay.
25
  To measure accurately the concentrations of cleaved peptide fragments, the N-terminal 
amines of the HNE substrate peptides were capped with acetic anhydride.  Peptides were 
dissolved in reaction buffer (50mM HEPES + 150mM NaCl pH 7.4) at varying concentrations 
and HNE was added (30nM).  The reaction mixture was sampled at 5-minute intervals and 
allowed to further react with fluorescamine (2mg mL
-1
 in acetonitrile) for determining the 
concentrations of cleaved peptides. (fluorescence was detected at !excitation=380nm, 
!emission=460nm, Perkin Elmer Wallac Victor
2
 1420 Multilabel Counter).  Cleavage product 
concentration was determined using pre-synthesized peptide fragments as an external calibration.  
Michaelis-Menten enzyme kinetic analysis was performed and specificity constants (kcat / Km) 
were determined using non-linear regression analysis (Graphpad Prism 5).  Substrate cleavage 
site was confirmed by RP-HPLC analysis.  The peptide fragments were isolated and analyzed 
with electrospray ionization mass spectrometry to determine the amino acid composition within 
the fragment. 
!
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Synthesis of HNE-cleavable FRET substrate   
The peptide K(ROX)AAPV!RGGGK(QXL) was synthesized as follows (where arrow 
indicates cleavage location).  Fmoc-Lys(Mtt)-OH was allowed to couple to the resin 
(HATU/DIPEA) for 2h.  The resin was then treated with 1.8% TFA in dichloromethane for 30 
seconds, repeated nine times
26
 to selectively remove the Mtt protecting group on Lys.  A 
ninhydrin test was performed to confirm the complete removal of the Mtt protecting group.  
QXL was then reacted to the deprotected "-amino group (HATU/DIPEA) on Lys for 2 h.  The 
resin was then thoroughly washed with DMF and placed on the ABI 433A Peptide Synthesizer 
for automated couplings.  After peptide synthesis, Fmoc-K(Mtt)AAPVRGGGK(QXL)-resin was 
removed from the instrument and the Mtt group selectively deprotected as described above.  
ROX was reacted to the N-terminal Lys "-amino group using HATU/DIPEA coupling chemistry.  
The terminal Fmoc group was manually removed (20% piperidine in DMF).  Finally, the product 
was cleaved from the resin and purified as described above.  The product was confirmed using 
MALDI-MS.  
Visualization of HNE activity in PEG hydrogel   
Acrylate-PEG-NHS (5 eq.) was reacted to the N-terminal amine of the FRET substrate in 
0.1M sodium phosphate buffer pH 8.0 for 4 h protected from light.  The desired product (Acryl-
PEG-K(ROX)AAPV!RGGGK(QXL)) was isolated using RP-HPLC and resulted in a 
lyophilized powder.  Upon HNE dictated cleavage, the QXL quencher is able to diffuse away, 
leaving fluorescent ROX that provides spatial evidence of HNE activity within our gels.  FRET 
hydrogels were formed from a precursor solution of 10 wt% PEGDA10k in phosphate buffer 
(PBS), 0.025wt% of the photoinitiator 2-hydroxy-1-[4-(hydroxyethoxy)phenyl]-2-methyl-1-
propanone (I-2959 , Ciba-Geigy) and 4mM Acryl-PEG-K(ROX)AAPVRGGGK(QXL), exposed 
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to 365nm ultraviolet light for 10 min.  Gels were treated with 1µM HNE and 3 dimensional 
fluorescence image stacks, spanning the thickness of the hydrogel, were captured at 
predetermined time points using confocal microscopy (Zeiss Pascal LSM 5).  ROX was excited 
using a 543nm helium-neon laser and fluorescence was collected using a 560nm long pass filter. 
HNE dictated release From PEG hydrogel  
Two HNE substrates analyzed using the solution phase assay were further studied in an 
immobilized hydrogel system.  Peptides AAPV!RGMG and AAP(Nva) !GGMG were acrylated 
with conjugation to APEG-NHS and purified as described above.  Methionine residues were 
substituted for cysteine residues, as used previously, to prevent thiol-acrylate reaction during 
photopolymerization. Hydrogels were formed via free radical photopolymerization from the 
macromer solution containing 10wt% PEGDA10k, 5mM APEG-peptide, and 0.025wt% I-2959 
under standard conditions described above. Cylindrical disks (diameter=5mm, thickness=600µm) 
were formed using a biopsy punch.  Roughly 85% of the APEG-peptide was incorporated during 
the photopolymerization, which is comparable to previous literature using similar reaction 
conditions.
27
 The gels were swelled in buffer for 24 h and the supernatant was exposed to HNE 
(1 µM).  The reaction was allowed to proceed for 2 h to ensure complete substrate cleavage.  
Fluorescamine was added and the amount of peptide in the buffer solution was determined using 
an external calibration with the peptide fragment.  Gels (n=3) were then transferred to 100µL of 
fresh HEPES buffer and 1 µM HNE was added.  At predetermined time points, samples were 
analyzed for peptide fragment release using fluorescamine.  Buffer and enzyme was replenished 
at each time point. 
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3.4. Results and Discussion 
Solution phase enzyme kinetic analysis of HNE substrates 
To tailor drug delivery in enzyme responsive materials, it is important to characterize the 
kinetic rate at which the enzyme is breaking down its respective substrate.  HNE substrates were 
synthesized with point variations in the P1 and P1’ amino acid positions with the goal of 
manipulating the reaction kinetics.  Rational design was used to vary residues within these 
locations.  Previous literature reports that HNE specificity for its substrate depends greatly on S’-
P’ interactions.
28
  Therefore, we examined a charged amino acid (Arg), a neutral, hydrophilic 
residue (Gln), a hydrophobic, aliphatic amino acid (Leu), and a hydrophobic, aromatic residue 
(Phe) in the P1’ location (Table 1). Figure 3.2a shows that hydrophobic interactions play a 
dominant role in protein-peptide binding (~Km) similar to previous reports.
28
  Km values ranged 
from 150µM (Arg in P1’ position) to 50µM (Phe in P1’ position).  An increase in substrate 
hydrophobicity led to a decrease in Km values indicating enhanced protein-peptide affinity.  
Incorporation of an Arg residue enhanced the catalytic efficiency similar to studies by Korkmaz 
et al.
29
  A ~2.5 fold difference was seen in kcat values ranging from 3.1 s
-1
 to 1.3 s
-1
 for Arg and 
Phe P1’ containing peptides, respectively.  Electrostatic interactions could contribute to this 
result based on the surface charge distribution on HNE, as HNE exhibits a slightly negative 
surface charge in close proximity to the catalytic site.
29
   In addition, a scrambled peptide 
exhibited resistance to HNE cleavage showing specificity of the other substrates. 
 In further attempts to tailor the kinetic rate of HNE mediated substrate degradation, we 
studied the incorporation of non-natural amino acids in the P1 position (Table 1).  HNE is known 
to prefer short, aliphatic amino acids in the P1 site.
30,31
  The S1 pocket of HNE is shallow 
compared to its serine protease counterparts due to the presence of Val-190 and Val-216 
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residues.
32
  Therefore, we investigated non-native residues whose side chains differ by varying 
numbers of methylene groups.  Figure 3.2b indicates there is an preferred size of the P1 side 
chain length (Abu with ethyl group) for effective HNE substrate degradation.  HNE degraded 
substrates containing a short P1 amino acid side chain (Ala) and longer P1 residue side chains 
(Nle) at a rate constant of 0.18 s
-1
 and 0.07 s
-1
, respectively.  A maximum kcat constant (1.1 s
-1
) 
for P1 amino acid variations was found with an Abu (ethyl side chain) containing peptide.  The 
Michaelis-Menten constant remained similar (240µM - 290µM) for the P1 varied substrates 
indicating comparable protein-peptide affinity.  These results demonstrate that the point 
variations on HNE substrate peptides affect the catalytic activity of HNE.  Figure 3.2c contains a 
representative Michaelis-Menten plot (substrate: Ac-YAAPVRGCG-NH2) illustrating the 
enzyme kinetics of HNE dictated substrate cleavage.  Further, HPLC was used to separate the 
peptide fragments and non-degraded peptide within an HNE-peptide containing reaction mixture.  
Non-degraded peptide and two peptide fragment peaks are observed in Figure 3.2d 
corresponding to Ac-YAAPVRGCG-NH2 and Ac-YAAPV/RGCG-NH2, respectively (MALDI 
spectra can be found in Supporting Information).  
In conclusion, it was possible to alter the rates of HNE-dictated cleavage by simply 
varying a single amino acid residue in specific locations along the substrate sequence.  The 
results presented herein provide the foundation for achieving tailorable HNE-responsive drug 
delivery from PEG hydrogels. 
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Visualizing HNE activity in a PEG hydrogel using FRET 
When designing enzyme responsive delivery platforms, it is critical to understand the 
accessibility of the substrate to the enzyme.
33
  PEGDA photopolymerized hydrogels are highly 
crosslinked, 3-dimensional polymeric networks.  This structure impedes (and at some molecular 
weight cut off denies) the diffusion of proteins through the hydrogel network.  Other than 
pathological reasons, HNE was chosen as a triggering molecule due its relative small size 
(~29.5kDa) and ability to penetrate the hydrogel.
34
  By incorporating a FRET based HNE 
substrate within the hydrogel, HNE spatial activity could be visualized using confocal 
microscopy.  We developed a FRET hydrogel system where a fluorophore/quencher HNE 
Figure 3.2 Solution phase hydrolysis of peptides by HNE.  kcat & Km values for point 
variations in the P1’ (a) and P1 (b) substrate positions.  Kinetic constants for the control 
substrate Ac-YAAPV!GGCG were Km = 160 ± 20 µM and kcat = 2.68 ± 0.08 s
-1
. Arrow 
indicates cleavage location. c) Representative Michaelis-Menten plot. d) Representative 
HPLC chromatogram showing pure peptide (dashed line) and peptide and HNE reaction 
mixture (solid lines). 
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substrate (K(ROX)AAPV!RGGGK(QXL)) was photopolymerized within a PEG hydrogel.  
Upon HNE dictated cleavage, the QXL quencher was able to diffuse out of the gel allowing for 
the detection of the ROX fluorophore.  Figure 3.3 shows the enzyme cleavage front as a function 
of space and time.  Figure 3.3a shows a uniform fluorescence profile over the thickness of the 
hydrogel.  Over time, an increase in normalized fluorescence was initially observed at the gel 
edges and propagated inwards toward the center.  At t=10 minutes, increased uniform 
fluorescence (~2.5 times the initial value) was observed through the z-direction of the gel.  Our 
results indicate that HNE is able to access the center of the hydrogel within a reasonable time 
scale (minutes), but both mass transfer and kinetics are important in dictating the overall release 
profile. 
 
 
 
 
 
 
 
 
 
Modeling enzymatic cleavage and release from PEG hydrogel 
To predict release profiles from this system, a reaction-diffusion model was developed, 
based on similar approaches in the literature.
35,36
  Briefly, substrate cleavage was assumed to be 
governed by Michaelis-Menten kinetics (Figure 3.2) with a spatially heterogeneous HNE 
!
Figure 3.3 Spatial HNE activity progression at a) 0 min b) 1 min c) 3 min d) 5 min and e) 
10 min throughout the thickness of a hydrogel.  Scale bars = 200µm.  Graphs depict 
quantitative fluorescence analysis as a function of a representive hydrogel thickness. 
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concentration dictated by HNE’s diffusion into the gel as well as its measured half-life.  The 
cleaved product then diffused out of the hydrogel and the product residing in the supernatant at 
each time point was measured.   
The diffusion of HNE was modeled by unidirectional, Fickian diffusion through the 
vertical axis of the hydrogel such that   
                                          
! 
"[HNE](z,t)
"t
=D
E
" 2[HNE](z,t)
"z2     (1) 
 
where DE is the diffusion coefficient of the enzyme in the gel and [HNE] is the concentration of 
enzyme at a given point in space and time.  The diffusion coefficient of HNE (DE=5 x 10
-7
 cm
2
 
sec
-1
) was estimated from studies with a similar size protein (carbonic anhydrase) diffusing 
through a hydrogel with similar gel chemistry.
34
 At the surface (x = 0) of the hydrogel, a 
boundary condition was set as [HNE] = [HNE]0, where [HNE]0 is the concentration of enzyme in 
solution.  At the center of the gel, the symmetry boundary condition was employed.  Solving Eq. 
(3.1) and the corresponding boundary conditions leads to the solution:  
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where h is the half-thickness of the gel (h = 300 µm).  Using the spatial profile of enzyme 
concentration from Eq. (3.2) and assuming that the cleavage of substrate follows Michaelis-
Menten kinetics, the amount of substrate cleaved and product formed at each point in the gel is 
predicted by the following kinetic equations: 
! 
"
#[S](z,t)
#t
=
#[P](z,t)
#t
= [HNE](z,t)k
cat
[S]
Km + [S]   (3.3)
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 where [S] is the concentration of substrate, kcat is the kinetic constant for formation of product 
for the given HNE-substrate pair as measured in solution, Kmis the Michaelis constant for the 
given HNE-substrate pair as measured in solution, [P] is the concentration of cleaved product.  
The diffusion of the cleaved product is also modeled by unidirectional, Fickian diffusion through 
the vertical axis of the gel such that 
! 
"[P](z,t)
"t
=DP
" 2[P](z,t)
"z2     (3.4)
 
where DP is the diffusion coefficient of the cleaved product in the gel.  The product diffusion 
coefficient in dilute solutions was first approximated using the Stokes-Einstein equation (Eq. 
(3.5)). 
! 
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     (3.5) 
Using a correlation developed by Lustig et al.,
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 DP in a crosslinked hydrogel was calculated to 
be 4.0 x 10
-6
 cm
2
 sec
-1
.  This relationship can be used to approximate the diffusion of various 
molecules, such as small molecules or globular proteins, since it takes into account the 
hydrodynamic radius of the solute, the mesh size of the crosslinked network, and the volume 
degree of swelling for the gel.   Product diffusion was modeled numerically using a second-
order, centered difference approximation of the second-derivate. 
Figure 3.4 shows the experimentally measured and predicted release profiles using two 
HNE substrates (AAPVRGMG, AAP(Nva)GGMG) and varying concentrations of HNE.  The 
two substrates examined were chosen based on the varying catalytic rates determined previously. 
Figure 3.4a shows varying release rates as a function of HNE concentration with the 
incorporation of substrate AAPVRGMG.  Exogenously adding 1µM HNE resulted in complete 
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peptide release circa 1 hr whereas 100nM HNE dictated release occurred over 6 hrs. Figure 3.4b 
illustrates peptide release profiles from incorporated substrates with varying enzyme kinetic 
rates.  For all systems where the reaction rate was increased (increased [HNE] or kcat) there was 
an increasing linear release response at t!0.  However, when the rate of reaction was decreased 
(decreased [HNE] or kcat), the data depicts an initial delay in release, which is most likely 
attributed to diffusion limitations.  The model agrees with the experimental values up to 80% 
release.  At this point, the model and the experimental results deviate, which is likely due to the 
complexity of the system at later time points.  As substrate is being converted to product, free 
carboxylic acids are present forming a more polyelectrolyte hydrogel.  Upon HNE cleavage, the 
peptide fragments diffusing out of the gel (product) are cationic.  Electrostatic attraction between 
the gel and the product could potentially decrease the diffusion rate out the gel,
38
  This 
phenomenon would result in the mathematical model over predicting the rate of release as 
observed.  
These results focus on the ability to tune release from the developed platform.  To further 
enhance the value of the system, anti-inflammatory therapeutics can be covalently attached to the 
released peptide fragment through various bioconjugation techniques.  In specific, small 
molecule drugs such as lisofylline,
39
 ketoprofen,
40
 and D-penicillamine
41
 are of interest due to 
their function and ability to incorporate onto the HNE substrate. 
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Figure 3.4 Peptide release profiles as a function of time from hydrogel in the presence of a.) 
varying HNE concentrations and b.) varying HNE substrates.  Solid lines indicate diffusion-
reaction model results.  Error bars indicate standard deviation (n=3). 
 
3.5. Conclusion 
An enzyme responsive PEG hydrogel platform was developed to achieve HNE triggered 
release to the local environment. The rate of enzyme reaction (substrate degradation) can be 
tailored by incorporation and/or substitution of different amino acids in specific locations of the 
substrate. A novel FRET-based hydrogel platform was fabricated to image enzyme activity 
throughout the thickness of the macroscopic gel.   The release from the hydrogel can be modeled 
using a diffusion-reaction model with molecular diffusion and Michaelis-Menten kinetics. This 
work fully characterized the drug delivery platform and exhibited the ability to achieve local, 
controlled release in the presence of HNE.  In addition, this system could be further expanded to 
target other cell-secreted enzymes to target different stages of inflammation.  Further studies 
involving conjugation of an active therapeutic to the substrate are necessary to validate the 
system. 
!
!
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3.8. Supporting Information 
 
Figure S3.1 
1
H NMR of PEGDA10k.  Comparison of the acrylate peaks to the -CH2- backbone 
peaks results in a calculation of ~94% functionalization of the final PEGDA10k. 
 
Figure S3.2 MALDI-TOF spectra correlating to a.) pure Ac-YAAPVRGCG and b.) a mixture of 
Ac-YAAPVRGCG, Ac-YAAPV, and H2N-RGCG. 
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4. Chapter 4 
Poly(ethylene glycol) hydrogels formed by thiol-ene photopolymerization for enzyme-
responsive protein delivery 
Manuscript appearing in Biomaterials, 30 (30), 6048-6054 (2009). 
 
4.1. Abstract 
Degradable hydrogels have been extensively used in biomedical applications such as 
drug delivery, and recent interest has grown in hydrogels that degrade in recognition of a cellular 
response.  This contribution describes a poly(ethylene glycol) (PEG) hydrogel platform with 
human neutrophil elastase (HNE) sensitive peptide cross-links formed using thiol-ene 
photopolymerization rendering the gel degradable at sites of inflammation. Further, protein 
therapeutics can be physically entrapped within the network and selectively released upon 
exposure to HNE.  HNE responsive hydrogels exhibited surface erosion where the degradation 
kinetics was influenced by changes in peptide kcat, concentration of HNE, and concentration of 
peptide within the gel.  Using this platform, we were able to achieve controlled, zero-order 
release of bovine serum albumin (BSA) in the presence of HNE, and release was arrested in the 
absence of HNE. To further exploit the advantages of surface eroding delivery systems, a smaller 
protein (carbonic anhydrase) was delivered at the same rate as BSA and only dependent on gel 
formulation and environmental conditions. Also, protein release was predicted from a 3-layered 
hydrogel device using mass loss data.  Lastly, the bioactivity of lysozyme was maintained above 
90% following the exposure to thiol-ene photopolymerization conditions. 
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4.2. Introduction 
In recent decades, hydrogels have been exploited as attractive materials for many biological 
applications including tissue engineering
1,2
 and drug delivery.
3
  Hydrogel cross-links render them 
insoluble, but the networks are capable of absorbing > 99% of their weight in water.  The 
hydrophilic nature of the material is desirable for many drug delivery applications where the 
intended therapeutic can denature because of hydrophobic interactions.
4
  In this regard, 
poly(ethylene glycol) (PEG) has been used extensively as a protein drug delivery platform.  PEG 
hydrogel network properties, such as mesh size
5
 and mechanical properties,
6
 are highly 
controllable. Additionally, proteins can be entrapped within this 3-dimensional network by 
inclusion in the prepolymer solution.  Previous release studies using PEG diacrylate (PEGDA) 
photopolymerized hydrogels have examined the diffusion of proteins out of highly cross-linked 
gels
7
. The protein release is diffusion controlled, and the release rate is subsequently tuned by 
varying the ratio of the mesh size to the size of the protein therapeutic.  However, this approach 
is only useful for systems when the protein size and the network mesh size are similar.  More 
recently, efforts have expanded in the synthesis of responsive hydrogels that are capable of 
releasing a protein upon an applied stimulus such as pH,
8
 temperature,
9
 glucose,
10
 or enzymatic 
activity.
11
 While these materials provide a biocompatible platform with the potential for 
controlled release applications, there remains a need for biomaterials to respond to cellular 
stimuli. 
As an alternative to diffusion-controlled release, researchers are interesting in designing 
intelligent drug delivery systems capable of achieving localized, controlled release of a 
therapeutic in recognition of a cellular event. One current approach involves covalently 
incorporating enzyme cleavage peptides as pendent groups within the network.
12-14
  While these 
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systems allow elegant control of the release for small biomolecules, the amount of drug that can 
be loaded within the hydrogel is limited. Also, the gel must allow for adequate enzyme diffusion, 
which can affect which protease is targeted or dictate the gel structural properties needed to 
allow for rapid diffusion.  Alternatively, peptides have been incorporated as cross-links within 
PEG hydrogels rendering the material degradable upon exposure to a particular enzyme. 
Collagenase sensitive peptides have been incorporated within a PEGDA monomer prior to gel 
formation to promote encapsulated cell migration.
15
  The advantage of this cell-responsive 
material is the method by which it is fabricated.  Photopolymerization serves as an efficient 
method for gel preparation. The photoinitiated reaction occurs under mild, aqueous conditions at 
room temperature with spatial and temporal control over the reaction kinetics.  These reaction 
conditions allow for the preservation of therapeutic efficacy during gel formation.  Also, 
photopolymerization allows for facile in situ gel formation and the ability to fabricate complex 
geometric devices.  However, some of the limitations of this material platform are the 
requirement for post-synthetic modification of the peptide for monomer preparation and the 
heterogeneous network structure that results from acrylate photopolymerization.
16
  
Another enzyme-responsive, PEG-based hydrogel platform that has been used for protein 
release relies on a Michael-type reaction for gel formation.
11,17,18
  A multi-arm PEG containing 
terminal vinyl groups can react selectively with a bis-cysteine peptide under basic conditions.  
This reaction serves as an effective way to incorporate enzyme cleavable peptides within 
hydrogel backbones by exploiting the sulfhydryl group on cysteine residues.  In addition, this 
reaction proceeds in a step-wise growth mechanism resulting in an ideal, homogeneous network.  
However, there is minimal control over the reaction in space and time.  In an attempt to utilize 
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the advantages of both hydrogel platforms with peptide cross-links, thiol-ene 
photopolymerization has been explored as a novel way to fabricate PEG-based hydrogels.
19
  
Thiol-ene photopolymerization is a highly efficient, radical mediated reaction between a 
thiol and an alkene.  A radical source, or photoinitiator in the presence of light, abstracts a 
hydrogen from a thiol forming a thiyl radical which can add across a carbon-carbon double bond.  
The subsequent propagation-chain transfer events result in a step-growth mechanism.
20
  Using 
this reaction mechanism for hydrogel formation allows for spatial and temporal control of 
polymerization, a resulting homogeneous network structure, and the ability to easily incorporate 
enzymatically degradable peptides within the backbone rendering the gel responsive to cellular 
events. 
This contribution presents the use of thiol-ene photopolymerization as a method for 
fabricating enzyme-responsive PEG hydrogels for the application of controlled protein release. 
In specific, we are interested in developing a material with the ability to treat inflammation 
locally.  Previous research has examined incorporating human neutrophil elastase (HNE), an 
enzyme present during inflammation, substrates within PEG hydrogels for controlled enzyme 
dictated release.
12
 This work examines the effect of HNE substrate (kcat), concentration of HNE, 
and concentration of substrate within the gel on the kinetics of enzyme triggered gel degradation 
and subsequent protein release.  The controlled, predictable delivery of a model protein (bovine 
serum albumin – BSA) was tailored by variations in hydrogel formulation.  Lastly, the effect of 
thiol-ene photopolymeriation on the bioactivity of an encapsulated protein was examined. 
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4.3. Experimental Section 
Materials 
4-arm poly(ethylene glycol) (PEG) was obtained from JenKem Technology USA. 5-
Norbornene-2-carboxylic acid was purchased from Sigma-Aldrich.  Fmoc protected amino acids 
in their L-configuration, as well as O-Benzotriazole-N,N,N’,N’-tetramethyl-uronium-hexafluoro-
phosphate (HBTU) used for amino acid activation, were obtained from Anaspec.  MBHA Rink 
Amide resin was purchased from Novabiochem. Bovine serium albumin (BSA), carbonic 
anhydrase (CA), and rhodamine B isothiocyanate (RBITC) were obtained from Sigma-Aldrich.  
Lysozyme and micrococcus lysodeikticus were purchased from Sigma-Aldrich and Worthington 
Biochemical Corp., respectively.  Human neutrophil elastase (HNE) was supplied as a 
lyophilized powder from Innovative Research. 
4-arm PEG-norbornene (PEG5k-norbornene) synthesis  
4-arm PEG (Mn~5,000) with terminal hydroxyls (-OH) was functionalized with 
norbornenes as follows.  5-norbornene-2-carboxcylic acid (24 mmol, 2.94 mL) and N,N'-
diisopropylcarbodiimide (DIC) (12 mmol, 1.86 mL) were reacted in dichloromethane (DCM) for 
30 minutes to form the anhydride.  In a separate round bottom flask (dried overnight), 4-arm 
PEG-OH (4 mmol, 5 g) was dissolved in 40 mL DCM.  To that, pyridine (20 mmol, 1.62 mL) 
and 4-dimethylaminopyridine (DMAP) (2 mmol, 0.24 g) were added.  The norbornene anhydride 
was then transferred to the PEG solution using a canula.  The reaction was allowed to proceed 
overnight at room temperature under an inert atmosphere.  Afterwards, the reaction was filtered, 
concentrated under rotary evaporation, and precipitated and washed (3x) in chilled diethyl ether.  
The product was verified with 
1
H NMR (Supporting Information, Figure S4.1). 
1
H NMR (500 
MHz, CDCl3) ! 6.28-5.79 (m, 2H), 4.24 – 4.09 (m, 2H), 3.78 – 3.43 (m, 112H). 
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Peptide synthesis  
HNE sensitive peptide sequences were synthesized (Protein Technologies, Inc Tribute 
Peptide Synthesizer) using solid phase Fmoc chemistry on a MHBA Rink Amide Resin (~0.7 
mmol g
-1
 resin substitution).  Amino acid coupling was performed using HBTU/N-
methylmorpholine (NMM) in N-methylpyrolidone (NMP).  Peptides were cleaved from the resin 
using trifluoroacetic acid (TFA)/triisopropylsilane (TIS)/water/D,L-dithiothreitol (DTT) 
(95/2.5/2.5 v/v) and allowed to react at room temperature for 2h.  The reaction was filtered and 
the filtrate precipitated and washed (3x) in chilled diethyl ether.  Peptides were purified by semi-
preparative reversed phase HPLC (Waters Delta Prep 4000) using a 70-min linear (5-95%) 
gradient of acetonitrile in 0.1% trifluoroacetic acid.  Peptide purity was confirmed by analytical 
reversed phase HPLC C18 column and matrix-assisted laser desorption ionization time-of-flight 
mass spectrometry (Applied Biosystem DE Voyager)(Supporting Information, Figure S4.2).    
Thiol-ene photopolymerization of PEG-based hydrogels 
PEG-peptide hydrogels were formed via thiol-ene photopolymerization (Figure 4.1).  Due 
to the step-wise mechanism of network development,
19
 thiol and norbornene functionalities were 
combined in equimolar concentrations.   PEG5k-norbornene and bis-cysteine HNE sensitive 
peptide accounted for 10% (w/w) (roughly 60 mM of functional groups) of the monomer 
solution. To that, the photoinitiator 2-hydroxy-1-[4-(hydroxyethoxy)phenyl]-2-methyl-1-
propanone (I-2959 , Ciba-Geigy) was added at a final concentration of 0.1 wt%.  The viscous 
solution was exposed to 365 nm light at an intensity of ~10 mW cm
-2
 for 10 minutes.  Gelation 
time and final elastic modulus were determined by dynamic time sweep rheology experiments 
using a modified ARES rotational rheometer (TA Instruments) operating in the linear 
viscoelastic region (strain=1%, frequency=100 rad s
-1
).  
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Figure 4.1 Schematic illustrating the design and formation of enzyme-responsive PEG hydrogels 
fabricated via thiol-ene photopolymerization (reaction mechanism included) for the controlled 
release of protein therapeutics.  Enzyme cleavage occurs between the P1 and P1’ amino acid 
residues. 
Hydrogel mass loss studies 
Hydrogel disks (diameter=5.1 mm, thickness=0.9 mm) were placed in buffer (0.05 M 
HEPES pH 7.4 + 150 mM NaCl) at 37°C.  HNE was added to initiate hydrogel degradation.  For 
experiments examining the kinetic effect of the HNE sensitive peptide and PEG molecular 
weight on gel degradation, the final concentration of HNE added was 1µM.  For experiments 
exceeding 2 h, the samples remaining were placed in fresh buffer and HNE to account for the 
half-life of the enzyme in vitro (t1/2~30min as determined using a commercially available HNE 
substrate).  During gel degradation, samples were removed at their respective time points, 
!
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washed (3x) in H2O, freeze dried for 24 h, and then weighed to determine the mass loss to that 
point.  
Protein release experiments 
Rhodamine-labeled protein BSA was used as a model protein to characterize release from 
the PEG-based hydrogels formed via thiol-ene photopolymerization.  Prior to gel formation, 
BSA was added to the monomer solution described earlier at a final concentration of 1 mg mL
-1
.  
After photopolymerization, gels were placed in buffer at 37°C for 2 h to release any protein 
present on the surface of the gel.  HNE was added to initiate protein release from the network.  
At predetermined time points, the release medium was sampled and replenished with fresh buffer 
and HNE.  Fluorescence was measured (!ex=550 nm !em=590 nm, Perkin Elmer Wallac Victor
2
 
1420 Multilabel Counter) to quantitate protein release. 
Protein release from layered hydrogel 
A three-layered hydrogel (diameter=5.1mm, thickness=1.2 mm, each layer thickness=0.4 
cm) was formed via sequential photopolymerizations.  The bottom and top layers were fabricated 
with a gel formulation comprised of PEG5k-norbornene and CGAAPVRGGGGC while the 
middle layer contained the monomers, PEG5k-norbornene and CGAAP(Nva)GGGGGC.  Each 
prepolymer solution contained BSA-rhodamine (1mg mL
-1
).  1µM HNE was added and 
fluorescence detected to determine protein release. 
Bioactivity of encapsulated protein  
Lysozyme was used as a model protein to determine if the radical-based, thiol-ene 
reaction had deleterious effects on the activity of the encapsulated biomolecule.  
Monofunctionalized PEG5k-norbornene (MeO-PEG5k-norbornene) and bis-cysteine peptide were 
used to achieve similar concentrations of active radicals during photopolymerization without 
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achieving a 3-dimensional, cross-linked network.  The prepolymer solution consisted of 10 wt% 
monomer (MeO-PEG5k-norbornene & peptide) and 2 mg mL
-1
 lysozyme.  The solution was 
exposed to 365 nm light (~10 mW cm
-2
) for 10 minutes to mimic hydrogel formation conditions.  
The solution was diluted 100-fold to assay for lysozyme bioactivity. Relative bioactivity was 
normalized to the positive control (native lysozyme solution). 
4.4. Results  
Rheological study of hydrogel polymerization via thiol-ene photochemistry 
 Figure 4.2 shows the time sweep measurement of the storage modulus (G’) and loss 
modulus (G”) over the time course of gel formation when irradiated with UV light.  Crossover 
point for gelation (an estimate of gel point conversion) was determined at the point when 
G’>G”.
21
  Based on this information, gelation occurs within 1 minute of light exposure and the 
gels reach a shear elastic modulus of ~6 kPa under typical photoinitation conditions (0.1 wt% I-
2959, 365 nm light, 10 min). Gel mechanical properties can be furthered tailored by varying the 
functionality or molecular weight of the starting macromolecules.  For example, the shear elastic 
modulus decreased to ~1 kPa when a 4-arm PEG-norbornene (Mn~20,000, PEG20k-nobornene) 
was used in the gel formulation (Supporting Information, Figure S4.3).  Gelation time and 
properties were unaffected with the incorporation of protein in the prepolymer solution 
(Supporting Information, Figure S4.4).  
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Figure 4.2 Dynamic time sweep photorheology of thiol-ene photopolymerization hydrogel 
formation with PEG5k. Gel point is approximated when the storage modulus (G’, •) overcomes 
the loss modulus (G”,!).  Dashed line (---) illustrates when the UV light was turned on to 
initiate polymerization. 
Characterization of HNE triggered gel degradation 
 Hubbell and coworkers demonstrated that enzyme-responsive hydrogel degradation is 
dependent on the peptide reaction constant (kcat), concentration of enzyme ([E]), and 
concentration of substrate within the intact gel ([S]o).
11
  Figure 4.3 shows the kinetics of 
hydrogel mass loss in the presence of HNE.  Varying the HNE-sensitive peptide cross-link 
affects the kinetics of enzyme reaction necessary to degrade the gel.  Gels with the HNE 
substrate CGAAPVRGGGC degraded within 2 hours of enzyme exposure. However, when 
CGAAP(Nva)GGGGC was used as a peptide cross-link a 2.5 fold increase in degradation time 
was observed likely due to the decrease in kcat.
12
 Decreasing the concentration of HNE can 
further reduce the kinetics of enzyme reaction. Figure 4.3b illustrates a 3-fold delay in gel 
degradation in the presence of 200 nM HNE compared to 1 µM HNE.  Since these gels are made 
with stoichiometric equivalents of norbornene to thiols, an increase in molecular weight of PEG 
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monomer inherently decreases the concentration of substrate within the hydrogel. Figure 4.3c 
shows the accelerated gel degradation when the peptide cross-link density is decreased. 
 It is also important to note that the mechanism for gel degradation is surface erosion as 
indicated by the linearity of the mass loss profiles.  To further confirm the mode of degradation, 
the equilibrium swelling ratio was monitored over time in the presence of enzyme. Figure 4.3d is 
a representative graph showing constant swelling ratio over the course of gel degradation.  
 
Figure 4.3 Gel mass loss profiles upon exposure to HNE (a-c).  Influence of HNE peptide cross-
link (a), concentration of HNE (b), and concentration of substrate (c) were experimentally 
studied.  (d) Representative equilibrium swelling ratio as a function of time in the presence of 
HNE.  All gels were made of 10 wt% monomer and exposed to 1µM HNE (unless otherwise 
noted). 
HNE triggered release of encapsulated protein from PEG hydrogels 
 To demonstrate the utility of this hydrogel platform for drug delivery applications, BSA 
was encapsulated and subsequently released upon gel degradation. Figure 4.4a shows varying 
!
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protein release curves when the HNE substrate was altered. No BSA release was observed over 
the time scale of the experiment in the absence of HNE (data not shown).  To further show the 
triggerable release mechanism, Figure 4.4b illustrates the on-off temporal control of protein 
delivery only in the presence of HNE.   
 
Figure 4.4 BSA release profiles in the presence of 1µM HNE. (a) Protein release from thiol-ene 
hydrogels fabricated with varying peptide cross-links. (b) Temporal control of protein release 
when HNE is dosed (!) and when it is removed (!).  HNE substrate: CGAAPV!RGGGGC. 
 Surface eroding delivery platforms are capable of releasing molecules, of varying sizes, 
at the same rate dictated by the gel formulation and the environmental conditions.
22
  Figure 4.5 
illustrates the similar release profile of a smaller protein, carbonic anhyrdrase (CA ~ 29 kDa) to 
that of BSA (~66 kDa) and the correlation with gel mass loss under the same experimental 
parameters. The protein release profile is dictated solely by gel degradation kinetics, which is 
characteristic of surface eroding delivery systems. 
!
 77 
 
Figure 4.5 Protein release from thiol-ene hydrogels as a function of fractional mass loss.  Each 
data point represents the same time.  Gel formulation: PEG5k-norbornene + CGAAPVRGGGC + 
protein (1mg mL
-1
). [HNE] = 1 µM. 
Predicting protein release from tri-layered hydrogel formed with thiol-ene photopolymerization 
 Extensive work has been done to develop models able to predict drug release from 
surface eroding systems.
23,24
  As shown previously, mass loss data agrees with fractional release 
profiles.  Therefore, by predicting mass loss we can accurately describe the release of a protein 
from a surface eroding system. The kinetics of mass loss is proportional to the surface area of the 
device.  In the case of thin hydrogel disks, the surface area remains relatively unchanged 
throughout degradation (i.e., 1-D erosion).  Mass loss can then be predicted with the following 
equations, 
 
! 
df
dt
= k , 
where f is the fractional mass loss and k (hr
-1
) is the slope.  Assuming constant density and 
surface area, a change in the sample dimension in the direction of degradation front (i.e., 
thickness) is decreased as,  
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! 
"
dl
dt
= k', 
where l is the length in a geometric direction and k’ is the degradation constant (mm hr
-1
) and, 
 
! 
k'= kl
o
, 
where lo is the original hydrogel thickness (mm).  
Figure 4.6 illustrates the ability to predict protein release from surface eroding, enzyme-
responsive hydrogels formed via thiol-ene photopolymerization.  The outer layers comprise of 
roughly 66% of the total volume of the gel.  Up to that point, the mass loss is predicted using a 
single rate of degradation (k’=0.41 mm hr
-1
)( Figure 4.6, solid line).  Upon reaching the inner 
layer containing a different peptide cross-link, a unique degradation rate constant (k’=0.18 mm 
hr
-1
) was implemented to achieve a decreased rate of release (Figure 4.6, dashed line).  By solely 
changing the geometry with materials of varying degradation kinetic constants, we have obtained 
a bimodal release profile with highly predictable kinetics. 
 
Figure 4.6 BSA release from 3-layered hydrogel formed by subsequent thiol-ene 
photopolymerizations. ! = PEG5k-norbornene + CGAAPVRGGGC + BSA (1 mg mL-1), ! = 
PEG5k-norbornene + CGAAP(Nva)GGGGC + BSA (1 mg mL
-1
). Solid (—) and dashed (- - -) 
lines represent predicted release. 
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Effect of thiol-ene photopolymerization on the bioactivity of lysozyme 
 Importantly, lysozyme activity was maintained above ~93% when exposed to the same 
conditions as thiol-ene photopolymerization for gel formation in the presence of macromers 
(Figure 4.7).  Free radicals formed by bond photolysis of the initiator when exposed to UV light 
attacked the protein in the absence of macromers significantly reducing the bioactivity to roughly 
12% and 4% in the presence of 0.1 wt% and 0.025 wt% I-2959, respectively, after 10 min.  
 
Figure 4.7 Influence of thiol-ene photopolymerization on the bioactivity of lysozyme in the 
presence of varying concentrations of photoinitiator, I-2959.  All samples were exposed to 365 
nm light for 10 minutes with or without macromers present in the prepolymer solution. 
4.5. Discussion 
 The scope of this contribution was to describe and characterize a method for hydrogel 
formation using thiol-ene photopolymerization for applications in controlled, enzyme-responsive 
protein delivery.  HNE was chosen as a targeted enzyme due to its high specificity to sites of 
inflammation.  During the onset of inflammation, neutrophils respond to infection by releasing a 
variety of biomolecules, including enzymes such as HNE.  Here we present a hydrogel drug 
!
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delivery platform with HNE-sensitive peptide crosslinks, which allow for gel degradation and 
subsequent protein release upon exposure to HNE.  These HNE-responsive gels exhibited 
surface erosion in the presence of enzyme.  Classic surface eroding platforms, such as 
polyanhyrides,
25,26
 exhibit surface erosion because the diffusion of water within the hydrophobic 
polymer is much slower than the kinetics of bond hydrolysis at the material surface.  Similarly, 
the diffusion of HNE (~29 kDa protein) within the matrix is severely hindered, if not completely 
inhibited in these cross-linked gels.  The mesh size of the thiol-ene gels was approximated using 
rubber elasticity theory
27-29
 and found to be on the same order of magnitude as the hydrodynamic 
radius of HNE.  The timescale for reaction appears to be faster than the timescale for molecular 
diffusion within the cross-linked hydrogel resulting in surface erosion. 
 Surface eroding biomaterials can be highly desirable for drug delivery application.  As 
shown previously, protein release rates are not dependent on the size of the protein.  In diffusion 
controlled drug delivery systems, the radius of the protein plays a critical role in the rate at which 
it is released.  However, in an enzymatically reaction controlled delivery system, the release of 
various biomolecules is dependent on factors influencing degradation (kcat, [E], [S]o).  By solely 
changing the gel formulation, highly controlled, tailorable zero-order release can be obtained.  
This characteristic can be exploited in a multi-layered hydrogel platform formed by subsequent 
photopolymerizations.  This layered device could also be used to achieve sequential, controlled 
delivery of multiple proteins where the release can be predicted based on 1-D mass loss 
experiments. 
 Although photopolymerization reaction conditions are considered mild, it is still 
important to consider the potential high-energy free radical interaction with encapsulated protein 
therapeutics.  Lin et al. hypothesized mechanisms of protein inactivation exposed to acrylate 
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photopolymerization.
30
  In addition, (meth)acrylates non-specifically react with proteins in the 
presence of a radical source, which could affect the bioactivity.
31,32
  The potential advantage of 
thiol-ene photopolymerization for protein encapsulation is the minimal interaction the monomers 
would have with the protein.  Most of the cysteine residues are disulfide bridged within proteins 
resulting in minimal free thiols.  Additionally, if modification of the protein did occur through an 
available thiol, PEGylation of a protein has been shown to enhance its stability in circulation.
33,34
  
BSA is known to contain 1 free thiol; however, the crystal structure shows that it is not located at 
the surface indicating it would not participate in the photoreaction of macromers.
35
  
Photorheology of a prepolymer solution containing BSA was examined (Supporting Information 
Fig. S2).  The final elastic modulus was similar for thiol-ene gels formed in the presence or 
absence of BSA suggesting minimal interactions with the protein during photopolymerization. 
The advantages of forming hydrogels for drug delivery applications via photopolymerization are 
well known, however, it is still important to select a reaction mechanism capable of rapidly 
forming a hydrogel with minimal deleterious interactions with the protein.  
4.6. Conclusion 
Thiol-ene photopolymerization for biomedical applications was recently presented as a 
novel mechanism for hydrogel formation.  We exploited this technique to fabricate protein 
delivery vehicles capable of enzyme responsive protein release at sites of inflammation. 
Controlled, tailorable mass loss profiles exhibiting surface erosion were obtained by varying 
kcat, concentration of HNE, and concentration of substrate.  The advantages of surface eroding 
platforms were exploited to release various size proteins on the same time scale dictated by gel 
formulation.  Additionally, the release can easily be predicted from more complex hydrogels 
using 1-dimensional mass loss data.  And finally, lysozyme retains ~93% of its bioactivity post 
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thiol-ene photopolymerization.  This delivery platform has potential application for treatment of 
disease where inflammation has been implicated such as diabetes,
36
 rheumatoid arthritis,
37
 and 
cancer.
38
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4.9. Supporting Information 
 
Figure S4.1 
1
H NMR of 4-arm PEG5k-norbornene shows roughly 90% norbornene 
modification. 
 
Figure S4.2 HPLC chromatogram and MALDI-TOF spectra for CGAAPVRGGGGC (a-b) and 
CGAAP(Nva)GGGGGC (c-d), respectively. 
!
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Figure S4.3 Dynamic time sweep rheology of PEG20k-norbornene and CGAAPVRGGGGC.  
Gelation occurred within the first minute and the final storage modules (G’) was ~1kPa. 
 
 
Figure S4.4 Dynamic time sweep rheology (PEG5k-nobornene + CGAAPVRGGGGC) of the 
storage modulus (G’) in the presence of absence of BSA (1 mg mL
-1
). 
!
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5. Chapter 5 
On-resin peptide macrocyclization using thiol-ene click chemistry 
Manuscript appearing in Chemical Communications, 46 (23), 4061-4063 (2010). 
 
5.1. Abstract 
A versatile and rapid synthetic strategy has been developed for the on-resin cyclization of 
peptides using thiol-ene photochemistry.  This unique method exploits the thiol group of natural 
cysteine amino acids and allows for various alkenes to be incorporated orthogonal to the peptide 
backbone. 
5.2. Introduction 
Peptides have gained interest in the fields of chemical biology and drug discovery
1
 due to 
their ability to bind to highly selective receptors of therapeutic interest.  Additionally, peptides 
can be synthetically produced and optimized allowing for large-scale production.  However, the 
drawbacks of peptide therapeutics are their short half-lives in vivo, poor bioavailability, and 
decreased cell permeability. Peptide macrocyclization, including peptide stapling,
2,3
 has been 
shown to address these limitations and result in a molecule with increased potency.  Cyclic 
peptides show increased stability to proteolytic degradation
4
 relative to their linear precursors 
and are able to bind to their intended target at decreased effective concentrations, mainly 
attributed to the constrained conformation lowering the entropic cost of binding.
5
  
 The synthesis of cyclic peptides has been traditionally achieved, both on resin or in 
solution, by the formation of disulfide,
6
 amide,
7
 ester,
8
 olefin,
9,10
 and C-C bonds.
11
  While these 
strategies result in peptide cyclization, the process can be extensive with reaction times ranging 
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from hours to days.  Due to the potential clinical advantages of cyclic peptides, there remains an 
unmet need to develop rapid and efficient synthetic strategies for their formation.  As a result, 
researchers have become increasingly interested in using alternative synthetic strategies based on 
“click” reactions, termed by Sharpless, to achieve site-specific conjugation between two 
functional groups in very high yields.  For example, the classic copper (I)-catalyzed azide-alkyne 
cycloaddition click reaction has been recently exploited for the on-resin formation of peptide 
macrocycles.
12-14
 Alternatively, the thiol-ene click reaction is a radical mediated addition of a 
thiol to an alkene and has been utilized for the formation of dendrimers,
15
 polymeric 
networks,
16,17
 and disaccharides.
18
 This contribution demonstrates the thiol-ene click reaction as 
an efficient and unique method for rapid formation of cyclic peptides on-resin (Figure 5.1). 
 
Figure 5.1 Synthetic route to on-resin peptide macrocyclization using thiol-ene photochemistry. 
Conditions: 1. (i) 2% TFA/CH2Cl2. 2. (ii) DMPA (1eq), h! (365nm, 20mW cm
-2
), 20-60 min; 
(iii) TFA/TIPS/H2O.  Alkenes were incorporated using Fmoc-Lys(Alloc)-OH monomer (1, 3) or 
on-resin modification using 5-norbornene-2-carboxylic acid (2, 4). 
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5.3. Experimental Section 
Materials 
All reagents used were peptide synthesis grade unless otherwise noted.  Fmoc-Cys(Mmt)-
OH, Fmoc-Arg(Pbf)-OH, Fmoc-Gly-OH, Fmoc-Asp(OtBu)-OH, Fmoc-Ser(tBu)-OH, Fmoc-D-
Phe-OH, Fmoc-Lys(Alloc)-OH, and Fmoc-Lys(Dde)-OH were obtained from Anaspec (San 
Jose, CA). Rink Amide MBHA resin (~0.5 mmol/g resin) was purchased from Novabiochem (La 
Jolla, CA).  Piperidine, 1,8-diazabicyclo [7] undec-7-ene (DBU), and 2,6-lutidine were obtained 
from Sigma-Aldrich (St. Louis, MO).  N-methylmorpholine (NMM) and acetic anhydride were 
purchased from Fisher Scientific (Pittsburgh, PA).  N-methylpyrolidone (NMP), 
dimethylformamide (DMF), and diisopropylethylamine (DIPEA) were purchased from Applied 
Biosystems (Foster City, CA). O-Benzotriazole-N,N,N’,N’-tetramethyl-uronium-hexafluoro-
phosphate (HBTU) and 2-(1H-7-Azabenzotriazol-1-yl)--1,1,3,3-tetramethyl uronium 
hexafluorophosphate methanaminium (HATU) were obtained from Anaspec and ChemPep, Inc. 
(Wellington, FL), respectively.  Hydrazine monohydrate, trifluoroacetic acid (TFA), 
triisopropylsilane (TIPS), phenol and 5-norbornene-2-carboxylic acid were purchased from 
Sigma-Aldrich. 2,2-dimethoxy-2-phenylacetophenone (DMPA) photoinitiator was obtained from 
Ciba (Tarrytown, NY).  Azobisisobutyronitrile (AIBN) was obtained from Sigma-Aldrich and 
used as a thermal initiator. 
General peptide synthesis 
Peptides were built using Fmoc protected amino acids on a solid phase Rink Amide 
MBHA resin with an automated Tribute Peptide Synthesizer (Protein Technologies, Tucson, 
AZ).  Peptides were synthesized on a 0.50 mmol scale.  Fmoc deprotection occurred in 20% 
piperidine (v/v), 2% DBU (v/v) in NMP (2 x 5 min).  4 eq. (relative to resin) of activated amino 
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acids (amino acid:HBTU:NMM; 1:1:2) were added to the Fmoc-deprotected resin and allowed to 
reaction for 35 min.  After each coupling step, any unreacted sites were capped using 5% (v/v) 
acetic anhydride, 6% (v/v) 2,6-lutidine in NMP (10 min).  After on-resin cyclization, peptides 
were cleaved from their solid support using TFA/TIPS/H2O (95:2.5:2.5 (v/v)) and phenol (50mg 
mL
-1
 cleavage solution) and allowed to react for 2.5 h.  The filtrate was precipitated in and 
washed (3x) with chilled diethyl ether.  The product was collected by centrifugation and allowed 
to dry in a desiccator for 2 h.  Peptides were purified using RP-HPLC (Waters Delta Prep 4000) 
with a C18 prep column (Sunfire 30mm x 150mm) using a 70-min linear (5-95%) gradient of 
acetonitrile in 0.1% trifluoroacetic acid.  Peptides were characterized using analytical scale RP-
HPLC (XBridge 4.6mm x 50mm), MALDI-TOF MS (Applied Biosystem DE Voyager), and 
various NMR techniques. 
Ac-CRGDSfK(Alloc)-NH2 cyclization using thiol-ene chemistry 
Following standard solid phase peptide synthesis described previously, the cysteine 
residue was deprotected by cleaving the monomethoxytrityl (Mmt) group as described 
elsewhere.
19
 The availability of the free thiol was confirmed using a modified on-resin Ellman’s 
assay.
20
  At this point, the resin was split into 3 equal parts.   1/3 of the resin was treated with 
TFA to cleave the peptide from the solid support, as described previously, to form the linear 
peptide (1).  After purification and lyophilization, 1 was solubilized in methanol (2mM) with 1 
eq. DMPA.  The solution was irradiated with UV light (Omnicure)(365nm, ~20mW cm
-2
, 1hr).  
DMPA was supplemented every 10 min to account for initiator consumption.  The product was 
concentrated by rotary evaporation and subsequently precipitated in cold diethyl ether and 
washed (3x). Another portion of resin was transferred to a round bottom flask with a stir bar, 
purged with Ar, and allowed to swell in DMF for 30 min.  DMPA photoinitiator (1 eq. to resin 
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functional groups) was added to the round bottom flask and allowed to diffuse throughout the 
macroporous beads for 10 min.  The resin was then exposed to UV light (365nm, ~20mW cm
-2
, 
1hr).  DMPA was supplemented every 10 min to account for initiator consumption.  The reaction 
was assumed complete when the Ellman’s assay resulted in a negative test for free thiols.  The 
resin was then washed with DCM (3x) and dried.  The peptide was cleaved from the solid 
support as described above.  The final portion of resin was added to a round bottom flask with 5 
eq of AIBN in DMF.  The reaction was performed at 65°C for 48 hrs under Ar.  The on-resin 
Ellman’s assay was used to determine when the reaction was complete.  The peptide was cleaved 
from the resin as described previously. 
Ac-CRGDSfK(Alloc)-NH2 (cyclic (2) & linear (1)) peptide characterization 
Peptides were characterized using RP-HPLC (Figure S5.1) and MALDI-TOF (Figure 
S5.2). NMR spectra were obtained on a Varian Inova-600 NMR spectrometer operating at 
599.71 MHz for 
1
H observation.  The instrument is equipped with a cryogenically cooled inverse 
geometry HCN ColdProbe, with the sample temperature maintained at 37.0°C.  2D-NMR 
experiments were performed as follows: COSY: gCOSY experiment, presented in magnitude 
mode; NOESY: gradient-enhanced, NOESY pulse sequence, with zero-quantum filter to 
minimize COSY cross peaks; HSQC: adiabatic gradient-HSQC using a matched adiabatic sweep 
to minimize loss of signal due to mismatch of JCH coupling constant. 
13
C adiabatic decoupling 
utilizing a “clean-WURST” decoupling sequence was used; HMBC: a gradient-selected HMBC 
sequence was used, with data presented in magnitude mode, with the long-range C-H coupling 
delay optimized for a coupling constant of 8.5 Hz.  All NMR spectra shown were processed and 
presented using the MestreNova 6.0 software package by Mestrelab Research, S.L.  The NMR 
samples consisted of 3 mg of compound dissolved in DMSO-d6 (600µL).  
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Ac-CRGDSfK(Norbornene)-NH2 cyclization using thiol-ene chemistry 
 Ac-C(Mmt)RGDSfK(Dde)-resin was built on the solid phase as described previously.  
The Dde group was selectively deprotected on-resin (2% hydrazine in DMF).
21
  A positive 
Kaiser test confirmed the availability of the !-amino group.  5-norbornene-2-carboxylic acid (4 
eq to resin, 244 µL), HATU (4 eq to resin, 760 mg), and DIPEA (8 eq to resin, 696 µL) in DMF 
were added to the resin and allowed to react for 1 hr.  A negative Kaiser test confirmed complete 
coupling.  Next, the resin was washed (5x) with DCM and the Mmt protecting group was 
subsequently removed as described previously.  The resin was partitioned similarly to the RGD 
derivatives containing the allyl ester.  The on-resin and solution cyclization photoreaction was 
performed as described above however the thiol-ene photoreaction with the norbornene reached 
completion in 20 minutes.  Thermal reactions were performed as described above.  Peptides were 
cleaved from the resin as described previously. 
Ac-CRGDSfK(Norbornene)-NH2 (cyclic (4) & linear (2)) peptide characterization 
Peptides were characterized using RP-HPLC and MALDI-TOF (Figure S5.8).  NMR 
spectra was obtained on a NMR spectra were obtained on a Varian VNMRS-800 NMR 
spectrometer operating at 799.33 MHz for 
1
H observation.  The instrument is equipped with a 
cryogenically cooled inverse geometry, HCN ColdProbe, with the sample temperature 
maintained at 25.0°C.  This probe is optimized for enhanced 
13
C sensitivity via cryogenically 
cooled detection coil and receiver pre-amplifier, which yields an increase of approximately 6x in 
sensitivity for direct 
13
C observation, making it possible to observe 
13
C directly for this sample.  
2D-NMR experiments were performed as follows: COSY: phase-sensitive DQF-COSY 
experiment, presented in pure-phase mode for improved resolution; NOESY: gradient-enhanced, 
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NOESY pulse sequence, with zero-quantum filter to minimize COSY cross peaks; HSQC: 
adiabatic gradient-HSQC using a matched adiabatic sweep to minimize loss of signal due to 
mismatch of JCH coupling constant. 
13
C adiabatic decoupling using a “clean-WURST” 
decoupling sequence was used; HMBC: a gradient-selected HMBC sequence was used, with data 
presented in magnitude mode, with the long-range C-H coupling delay optimized for a coupling 
constant of 8.5 Hz.  All NMR spectra shown were processed and presented using the 
MestreNova 6.0 software package by Mestrelab Research, S.L.  The NMR samples consisted of 
3 mg of compound dissolved in D2O.  
13
C chemical shifts were referenced indirectly to 0ppm in 
the 
1
H NMR spectrum according to the IUPAC method.
22
  The 
1
H NMR spectra were referenced 
using the residual HOD (water) signal at 4.77ppm (HOD at 25°C). 
Fibrinogen binding ELISA 
A 96-well Maxisorp plate (Nunc) was coated with GPIIb/IIIa (10 µg mL
-1
, 100µL) and 
incubated at 4°C overnight.  The plate was washed (5x) with buffer (50mM Tris-HCl, 100mM 
NaCl, 2mM CaCl2, 0.05% Tween20, pH 7.4).  Blocking solution (3.5% BSA, 100 µL) was added 
to the well and incubated at 37°C for 3 hr.  The plate was washed (5x) with buffer.  Peptides (50 
µL) and fibrinogen (40nM, 50 µL) were added to the plate and incubated at room temperature for 
3 hr.  The plate was washed (5x) and antibody (goat polyclonal to fibrinogen (HRP), 1:20,000 
dilution, 100 µL) was added to the plate and incubated for 1 hr at room temperature.  The plate 
was washed (5x) and substrate (2,2'-azino-bis(3-ethylbenzthiazoline-6-sulphonic acid, ABTS, 
100 µL) was added to the wells and allowed to react for 5 min.  The absorbance was measured 
(Perkin Elmer Wallac Victor
2
 1420 Multilabel Counter) at 405 nm.  The data was analyzed using 
Graphpad Prism 5. 
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5.4. Results and Discussion 
Our strategy utilizes the natural amino acid, cysteine, as the thiol source for the reaction.  
However, peptides can be designed to contain cysteine residues that do not participate in the 
cyclization reaction by exploiting highly selective orthogonal Cys protecting groups. Various 
alkenes and their effect on the cyclization were studied. Commercially available Fmoc-
Lys(Alloc)-OH was used as a building block to incorporate an allyl ester within the peptide 
sequence.  The allyloxycarbonyl (Alloc) functional group is traditionally used as an orthogonal 
protecting group for lysine amino acids during peptide synthesis.  However, recently the 
Lys(Alloc) monomer has been included within a peptide sequence to participate in a thiol-ene 
photoreaction to pattern within a hydrogel.
23,24
 We have exploited this commercially available 
building block as a facile method to incorporate an alkene within the peptide sequence.  
Alternatively, a strained, bicyclic alkene (norbornene) was incorporated orthogonally to the 
peptide backbone, as this alkene exhibits higher reactivity.
16
 Arg-Gly-Asp (RGD), a peptide 
ligand of the !v"3 integrin,
25
 was synthesized as a model peptide to demonstrate proof of concept. 
Figure 5.1 illustrates the general procedure for cyclic peptide formation.  Linear Ac-
C(Mmt)RGDSfK(alkene)-NH2 (1-2) was built on the solid phase using Fmoc chemistry.  The 
monomethoxytrityl (Mmt) sulfhydryl protecting group was selectively removed on-resin using 
2% TFA/CH2Cl2.  A type I photoinitiator, 2,2-dimethoxy-2-phenylacetophenone (DMPA), was 
added to the peptidyl resin and exposed to 365 nm light.  The reaction was well mixed to 
minimize the impact of light attenuation.  An on-resin Ellman’s test (2.5 mM 5,5'-dithiobis-(2-
nitrobenzoic acid) and diisopropylethylamine in methanol) was utilized to qualitatively monitor 
the extent of thiol conversion.
20
 The reaction with the allyl ester reached completion (based on 
Ellman’s test) at 1 hr.  However, the reaction with the strained norbornene reached completion 
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after just 20 min.  On-resin photocyclization of 4 and 2 were recovered at 37% and 24% yield, 
respectively (calculated based on initial resin substitution). 
 Further, cyclic products were also obtained using a thermal initiation scheme as well as a 
solution phase photoreaction using unprotected linear peptides (1 and 3).  Isolated yield 
calculations for each synthetic route can be found in Supporting Information Table S5.1.  
Thermal reactions performed at 65°C using azobisisobutyronitrile (AIBN; t1/2, 65°C~10hr) 
required longer reaction times (~48 hr) and resulted in decreased yields relative to the on-resin 
photoreaction.  Additionally, linear peptide precursors were purified and solubilized in dilute 
concentrations (2mM) with DMPA and exposed to 365nm light to form their cyclic products.  
Although the yields for the cyclization reaction were comparable to the on-resin photoreaction, 
the need for two purification steps and additional work-up lead to decreased overall yield of the 
final product. 
 Cyclized products were characterized using various NMR techniques. Figure 5.2b 
illustrates unambiguous evidence of cyclization in regards to 4.  The HMBC spectrum shows 
proton shifts at the #4 position (
1
H ! 2.97-2.85 ppm, diastereotopic protons influenced by the 
endo/exo conformation of the norbornane ring) that correlate with the carbon assignment at 
position #62 (
13
C ! 47.87, 47.08 ppm) as shown using HSQC data.  Further, Figure S5.14 
(Supporting Information) confirms the presence of NOEs between protons 4, 2, 51 (Figure 5.2a) 
and protons associated with the norbornane ring.  As expected, cyclic peptides eluted earlier than 
its linear counterpart using RP-HPLC (Figure 5.2c).   Spectral characterization for 1-3 can be 
found in Supporting Information. 
 98 
 
Figure 5.2 (a) Chemical structure of 4 containing numbered atoms. (b) NMR spectrum (HMBC 
(black) / HSQC (blue) overlay) confirming bond correlations across the thioether bond. (c) RP-
HPLC chromatogram highlighting varying elution times between cyclic (4) and linear (2) 
purified peptides. 
 To confirm the thiol-ene reaction did not exhibit deleterious effects on the cyclic peptides 
activity, a competitive binding ELISA was performed.  Glycoprotein IIb-IIIa (GPIIb/IIIa) is 
present on platelets and its binding to fibrinogen has been associated with platelet aggregation.  
RGD has been shown to inhibit the binding of GPIIb/IIIa to fibrinogen.
26
 Briefly, RGD peptide 
derivatives and fibrinogen were added to a Maxisorp 96-well plate coated with GPIIb/IIIa and 
incubated for 3h.  A goat polyclonal to fibrinogen antibody labelled with HRP was added (1h) 
and later detected using ABTS substrate and the absorbance measured at 405 nm. Figure 5.3 
shows the inhibition of fibrinogen binding to GPIIb/IIIa in response to 3 and 4 exhibiting an IC50 
values of 0.20 ± 0.09 and 0.36 ± 0.09 µM, respectively, which are comparable to reported 
literature values.
26
  The linear peptide (1) was less potent in inhibiting fibrinogen binding 
(IC50=1.41 ± 0.28 µM). 
!
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Figure 5.3 Inhibition of fibrinogen binding to GPIIb/IIIa in the presence of cyclic RGD 
derivatives formed via thiol-ene click chemistry. 
5.5. Conclusion 
In summary, we report the use of the thiol-ene click reaction for the on-resin 
macrocylization of peptides.  Peptides can be formed using commercially available amino acids 
without any post-synthetic modification (1, 3).  Alternatively a strained, alkene (norbornene; 2, 
4) can be utilized to achieve enhanced reaction kinetics and cyclization within 20 min.  This 
Communication demonstrates the thiol-ene click photoreaction as a facile method for the rapid 
synthesis (~20 min) of cyclic peptides with improved yields relative to other on-resin reactions. 
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5.8. Supporting Information 
 
Figure S5.1 RP-HPLC chromatogram of Ac-CRGDSfK(Alloc)-NH2 (linear-blue; cyclic-red) 
 
Figure S5.2 MALDI-TOF spectra corresponding to a) linear Ac-CRGDSfK(Alloc)-NH2 and b) 
cyclic Ac-c[CRGDSfK(Alloc)]-NH2. 
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Figure S5.3 
1
H NMR of linear Ac-CRGDSfK(Alloc)-NH2 (1) 
 
 
 
 
Figure S5.4 Structure of cyclic Ac-c[CRGDSfK(Alloc)]-NH2 (3). 
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Figure S5.4 illustrates a chemical drawing of cyclic Ac-c[CRGDSfK(Alloc)]-NH2. Cyclic 
Ac-c[CRGDSfK(Alloc)]-NH2 was characterized using 
1
H (Figure S5.5), HMBC (Figure S5.6), 
COSY (Figure S5.7), and NOESY (Figure S5.7) NMR. Figure S5.5 illustrates the disappearance 
of the vinyl protons (! 5.84 – 5.05) indicating a successful thiol-ene reaction. Figure S5.6 shows 
the chemical shift assignments of the methyl protons on the acetyl group (! 1.86, labeled 52 
Figure S5.4) and the proton (! 4.56, labeled 2 Figure S5.4) bonded to the "-carbon of the 
cysteine residue correlated through the carbonyl of the acetyl group (170.1 ppm).  Chemical 
shifts were assigned for protons 4 (! 2.84 – 2.69), 63 (! 3.98), 64 (! 1.76), and 65 (! 2.54) 
(Figure S5.4) using a COSY spectrum (data not shown). Figure S5.7 shows a COSY 
(red)/NOESY (grey) overlay.  This figure illustrates NOE’s that exist on protons adjacent to the 
thioether bond (proton 2 # proton 65; proton 4 # proton 65). 
 
 
Figure S5.5 
1
H NMR of cyclic Ac-c[CRGDSfK(Alloc)]-NH2 (3). 
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Figure S5.6 HMBC spectrum of cyclic Ac-c[CRGDSfK(Alloc)]-NH2. 
 
Figure S5.7 COSY (red)/NOESY (grey) overlay of Ac-c[CRGDSfK(Alloc)]-NH2. 
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Figure S5.8 MALDI spectra for a.) linear and b.) cyclic Ac-CRGDSfK(Norbornene)-NH2. 
The structure with numbered atoms can be found in Figure S5.9. Figure S5.11 is a 
HMBC spectrum illustrating the chemical shift assignment for proton 2 (! 1.86 ppm) correlated 
through the carbonyl on the acetyl group, which is assigned via the strong correlation to the 
acetyl-methyl protons. Figure S5.12 is a gDQF-COSY spectrum used to assign protons 4 
(diastereotopic; ! 2.97 – 2.85 ppm) and 61 (! 2.44 ppm). Figure S5.14 shows various NMR 
spectra and highlights the correlations within the molecule (magenta line). Figure S5.14a is a 
HMBC (black) / HSQC (blue) overlay showing the correlation through bonds between H4 and 
C62 (adjacent to thioether bond). Figure S5.14b and Figure S5.14c are COSY (blue) / NOESY 
(red) overlays showing the NOE’s present between H2 and various protons (62, 61, and 51) and 
NOE’s present between H4 and various protons (62 and 61). 
 
Figure S5.9 Structure of cyclic Ac-c[CRGDSfK(Norbornene)]-NH2 (4). 
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Figure S5.10 
1
H NMR of cyclic Ac-c[CRGDSfK(Norbornene)]-NH2 (4). 
 
Figure S5.11 HMBC spectrum of cyclic Ac-c[CRGDSfK(Norbornene)]-NH2. 
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Figure S5.12 gDQF-COSY spectrum of cyclic Ac-c[CRGDSfK(Norbornene)]-NH2. 
 
Figure S5.13 NOESY spectrum of cyclic Ac-c[CRGDSfK(Norbornene)]-NH2. 
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Figure S5.14 (a.) HMBC (black) / HSQC (blue) overlay. (b.) & (c.) COSY (blue) / NOESY 
(red) spectra of cyclic Ac-c[CRGDSfK(Norbornene)]-NH2. 
Table S5.1 Recovered yields of cyclic products (3 and 4) using various forms of initiation both 
on resin and in solution. 
 
a
Photoreactions performed with DMPA initiator irradiated with 365nm light. Thermal reactions 
performed with AIBN initiator at 65°C. 
b
Isolated yields are reported based on initial resin 
substitution. 
c
Includes combined yield of the linear precursor and cyclic product. 
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Linear 
Peptide
Initiationa
On-Resin / 
Solution
Cyclic 
Peptide
Yield (%) b
1 h! On-resin 3 24
h! Solution 12c
! On-resin 6
2 h! On-resin 4 37
h! Solution 13c
! On-resin 26
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6. Chapter 6 
Synthesis of cyclic, multivalent Arg-Gly-Asp using sequential thiol-ene/thiol-yne 
photoreactions 
Manuscript appearing in Chemical Communications, DOI:10.1039/c0cc01292k (2010). 
 
6.1. Abstract 
A unique method has been developed for the formation of multivalent cyclic peptides.  
This procedure exploits on-resin peptide cyclization using a photoinitiated thiol-ene click 
reaction and subsequent clustering using thiol-yne photochemistry.  Both reactions utilize the 
sulfhydryl group on natural cysteine amino acids to participate in the thiol-mediated reactions. 
6.2. Introduction 
Peptides and their applications as potential therapeutics have been revitalized within the 
past decade.  These biomolecules are capable of accessing both intra- and extracellular targets 
expanding the options relating to drug discovery.
1
 Further, peptides bind to ligands via natural 
protein-protein interactions, which small molecules only attempt to mimic.  This innate binding 
ability can cause the peptide to be more potent in comparison to a small molecule.
2
 Initially, 
peptides, derived as fragments from whole proteins, were unable to perform at or near the level 
of the native protein.  When these fragments are extracted from the protein, the short peptides are 
unordered and lack defined conformation leading to decreased activity.
3
 Further, peptides can be 
extremely unstable in vivo and are rapidly broken down by various proteases.
4
  
 Researchers have made great advances in addressing the inherent disadvantages related to 
peptide therapeutics.  Peptide macrocyclization, including peptide stapling,
5,6
 has rendered the 
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biomolecules more potent in binding to their intended target.  Additionally, peptides with a 
constrained conformation are more resistant to proteolytic degradation and are capable of 
achieving in vivo half-lives up to 24 hr.
6
 Macrocyclization has been reported, either on-resin or 
in solution, using a variety of ligation chemistries.  
 Additionally, multivalent interactions are known to play a critical role in many biological 
processes.
7
 The synthesis of multivalent peptides has further enhanced the interaction of 
individual ligands with their receptors.  Multiple antigenic peptides (MAPs) were discovered by 
Tam et al.
8
 and utilized a branched lysine core.  Although an elegant way to build multivalent 
peptides on the solid phase, the presence of single amino acid deletions made purification 
difficult.  More recently, researchers have looked for highly efficient, chemoseletive reactions to 
combine multiple peptides to a single core, or handle.  “Click” reactions, defined by Sharpless,
9
 
met the need for highly specific, rapid reactions between two functional groups in high yield for 
the synthesis of multivalent peptides.  Recent reports exploit the Cu(I)-catalyzed Huisgen azide-
alkyne 1,3-dipolar cycloaddition reaction as an effective way to conjugate azido containing 
peptides to a core molecule with multiple alkyne handles.
10-12
 These peptide dendrimers exhibit 
enhanced potency in relation to their monomeric counterpart.  However, there still remains a 
need for efficient reactions capable of achieving a molecule with a high density of peptide 
ligands. 
 Thiol-yne click chemistry
13,14
 has emerged within the last year as a highly efficient, 
radical-mediated reaction between a thiol and alkyne.  Two thiol groups can add across one 
alkyne making this a desirable reaction for the formation of multivalent peptides with increased 
peptide density.  Photoinitiated thiol-yne chemistry has been used for various polymer 
applications,
15-20
 as well as the formation of dendrimers.
21
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 This contribution presents the use of sequential thiol-mediated (thiol-ene/thiol-yne) 
photochemical reactions for the facile synthesis of cyclic, multivalent peptides (Figure 6.1).  
Recently, our group reported the first account of on-resin cyclic peptide formation using thiol-
ene photochemistry.
22
 We extended this work to introduce a free thiol to the cyclic peptide for 
subsequent clustering using thiol-yne photochemistry.  Arg-Gly-Asp (RGD), a peptide ligand of 
the !v"3  integrin, was used as a model peptide to illustrate proof of concept.  Biological activity 
of RGD derivatives was evaluated for their ability to prevent fibrinogen binding to glycoprotein 
IIb/IIIa (GPIIb/IIIa). 
 
Figure 6.1 Synthetic route to form multivalent peptides using thiol-yne photochemistry. 
Conditions: Photoinitiator (chosen based on peptide solubility), h# (365nm, 15 mW cm
-2
), 20 
minutes.  Note: Peptide cores with n=2,3 were synthesized with aminohexanoic acid (Ahx) 
linkers between alkynes.  See Supporting Information for more detail.  * indicates stereocenter 
generated by reaction. 
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6.3. Experimental Section 
Materials 
All reagents used were peptide synthesis grade unless otherwise noted.  Fmoc-Cys(Mmt)-
OH, Fmoc-Cys(Trt)-OH, Fmoc-Arg(Pbf)-OH, Fmoc-Gly-OH, Fmoc-Asp(OtBu)-OH, Fmoc-
Ser(tBu)-OH, Fmoc-D-Phe-OH, Fmoc-Lys(Mtt)-OH, Fmoc-Lys(Alloc)-OH were obtained from 
Anaspec (San Jose, CA). Fmoc-Ahx-OH and Rink Amide MBHA resin (0.56 mmol/g resin) 
were purchased from Novabiochem (La Jolla, CA).  Piperidine, 1,8-diazabicyclo [7] undec-7-ene 
(DBU), and 2,6-lutidine were obtained from Sigma-Aldrich (St. Louis, MO).  N-
methylmorpholine (NMM) and acetic anhydride were purchased from Fisher Scientific 
(Pittsburgh, PA).  N-methylpyrolidone (NMP), dimethylformamide (DMF), and 
diisopropylethylamine (DIPEA) were purchased from Applied Biosystems (Foster City, CA). O-
Benzotriazole-N,N,N’,N’-tetramethyl-uronium-hexafluoro-phosphate (HBTU) and 2-(1H-7-
Azabenzotriazol-1-yl)--1,1,3,3-tetramethyl uronium hexafluorophosphate methanaminium 
(HATU) were obtained from Anaspec and ChemPep, Inc. (Wellington, FL), respectively. 
Trifluoroacetic acid (TFA), triisopropylsilane (TIPS), phenol, 4-pentynoic acid, and (human) 
fibrinogen were purchased from Sigma-Aldrich. 2,2-dimethoxy-2-phenylacetophenone (DMPA) 
photoinitiator was obtained from Ciba (Tarrytown, NY).  GPIIb/IIIa was obtained from Enzyme 
Research Laboratories (South Bend, IN).  Fibrinogen antibody (HRP) was purchased from 
Abcam (Cambridge, MA).  
General peptide synthesis and purification 
Peptides were built on the solid phase using an automated Tribute Peptide Synthesizer 
(Protein Technologies, Tucson, AZ).  Peptides were synthesized on the 0.25-0.5 mmol scale.  
Fmoc deprotection was achieved using 20% piperidine in NMP (5min x 2).  4 eq. of Fmoc-
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protected amino acids were activated using HBTU/NMM (1:2, molar ratios of HBTU and NMM, 
respectively, in relation to amino acid) and added to the resin and allowed to react for 35 min.  
Any unreacted sites were acetylated using 5% (v/v) acetic anhydride/6% (v/v) 2,6-lutidine in 
NMP (10 min).  Peptides were cleaved from their solid support using TFA/TIPS/H2O (95:2.5:2.5 
(v/v)) and phenol (50mg mL
-1
 cleavage solution) and allowed to react for 2 h.  Peptides were 
precipitated in chilled diethyl ether and washed (3x).  Product was allowed to dry in a desiccator 
for 2h prior to HPLC purification.  Peptides were purified using RP-HPLC (Waters Delta Prep 
4000) with a C18 prep column (Sunfire 30mm x 150mm) using a 70-min linear (5-95%) gradient 
of acetonitrile in 0.1% trifluoroacetic acid. Peptides were characterized using analytical scale 
RP-HPLC (XBridge 4.6mm x 50mm), MALDI-TOF MS (Applied Biosystem DE Voyager), and 
1
H NMR. 
Synthesis of H-GK(4-pa)G-NH2 (Core 1) 
H-GK(Mtt)G-resin was synthesized as described in the General Peptide Synthesis 
section.  The Mtt group was selectively deprotected on resin as described previously.
23
  Briefly, 
1.5% TFA in dichloromethane was added to the resin (30 sec. x 9).  A positive Kaiser test 
confirmed the availability of the free amine.  4-pentynoic acid (4-pa; 5 eq. to resin) was then 
coupled to the !-amino group using HATU/DIPEA in DMF and allowed to react for 2 hr under 
Ar.  A negative Kaiser test confirmed successful coupling.  Product was characterized using 
MALDI-TOF and 
1
H NMR. MALDI: Calculated [M+H]
+
=340.4 g/mol, found [M+H]
+
=340.7 
g/mol. " 
1
H NMR (500 MHz, D2O) 4.29 (1 H, t, J 6.8), 3.92-3.83 (2 H, m, J 17.2), 3.84 (2 H, s), 
3.17 (2 H, t, J 6.3), 2.45 (2 H, d, J 6.2), 2.39 (2 H, t, J 6.7), 2.32 (1 H, s), 1.85 – 1.66 (2 H, m), 
1.56 – 1.46 (2 H, m), 1.37 (2 H, d, J 7.8). 
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Synthesis of H-GK(4-pa)G-Ahx-GK(4-pa)G-NH2 (Core 2) 
H-GK(Mtt)G-Ahx-GK(Mtt)G-resin was synthesized and 4-penytnoic acid was coupled 
through the Lys residues as described previously. MALDI: Calculated [M+H]
+
=775.9 g/mol, 
found [M+H]
+
=775.6 g/mol. ! 
1
H NMR (500 MHz, D2O) 4.32 – 4.22 (2 H, m), 3.90 (2 H, s), 
3.87 (2 H, d, J 8.5), 3.84 (4 H, d, J 4.7), 3.17 (6 H, t, J 6.5), 2.45 (4 H, d, J 6.4), 2.39 (4 H, t, J 
6.6), 2.32 (2 H, s), 2.28 (2 H, t, J 7.5), 1.75 (4 H, d, J 33.8), 1.62 – 1.54 (2 H, m), 1.49 (6 H, d, J 
7.0), 1.33 (6 H, dd, J 7.3, 38.6). 
Synthesis of H-GK(4-pa)G-Ahx-GK(4-pa)G-Ahx-GK(4-pa)G-NH2 (Core 3) 
H-GK(Mtt)G-Ahx-GK(Mtt)G-Ahx-GK(Mtt)G-resin was synthesized and 4-penytnoic 
acid was coupled through the Lys residues as described previously. MALDI: Calculated 
[M+H]
+
=1211.4 g/mol, found [M+H]
+
=1211.1 g/mol. ! 
1
H NMR (500 MHz, D2O) 4.32 – 4.18 (3 
H, m), 3.92 (4 H, d, J 18.3), 3.87 (2 H, d, J 8.9), 3.83 (6 H, t, J 4.6), 3.17 (6 H, d, J 6.8), 3.15 (4 
H, d, J 7.2), 2.45 (6 H, dd, J 5.2, 7.5), 2.38 (6 H, t, J 6.6), 2.32 (3 H, t, J 2.4), 2.28 (4 H, t, J 7.4), 
1.75 (6 H, d, J 34.4), 1.56 (4 H, dd, J 7.7, 15.2), 1.49 (10 H, d, J 6.7), 1.42 – 1.21 (10 H, m). 
Synthesis of H-CGGRGDS-NH2 (1) 
1 was synthesized according to the General Peptide Synthesis procedure. MALDI: 
Calculated [M+H]
+
=650.7 g/mol, found [M+H]
+
=650.6 g/mol. Yield: 82%. 
Synthesis of H-CGGc[CRGDSfK(Alloc)]-NH2 (2) 
Fmoc-C(Mmt)RGDSfK(Alloc)-resin was synthesized as described previously.  The 
monomethoxytrityl (Mmt) group was selectively deprotected on resin according to protocol.
24
  
An on-resin modified Ellman’s assay was used to qualitatively determine the presence of free 
thiol.
25
  Peptide cyclization was achieved using thiol-ene photochemistry as described 
elsewhere.
22
  Briefly, the resin was swollen in DMF (10 min) and the vessel purged with Ar.  
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DMPA (1 eq. to resin) was added and irradiated with UV light (365nm, 20 mW cm
-2
) for 3 hr.  
DMPA was supplemented every 10 min to account for initiator consumption due to photolysis.  
A negative Ellman’s test (indicating no thiols) was used to determine when the reaction was 
complete.  The remaining amino acids (Cys(Trt), Gly, Gly) were coupled (HATU/NMM) using 
the Tribute synthesizer. MALDI: Calculated [M+H]
+
=1112.3 g/mol, found [M+H]
+
=1112.2 
g/mol. 
1
H NMR confirmed the disappearance of vinyl protons. Yield: 15%. 
General procedure for the synthesis of multivalent RGD using thiol-yne photochemistry 
Cys-containing peptides (1 or 2) were dissolved in an appropriate solvent (0.2 M).  At 
this concentration, 1 was solubilized in H2O while 2 was dissolved in DMF.  The appropriate 
amount of core molecule was added to achieve a [SH]:[alkyne] ratio of 4:1 which was held 
constant for all reactions. Lithium phenyl-2,4,6-trimethylbenzoylphosphinate (LAP) was used as 
a water soluble (used with 1) Type I photoinitiator.
26
 2,2-dimethoxy-2-phenyl acetophenone 
(DMPA) was solubilzed in DMF (used with 2).  Photoinitiators were added at the following 
molar rations [SH]:[initiator]=50:1.  The reaction mixture was purged with Ar and irradiated 
with UV light (365nm, 15mW cm
-2
) for 20 minutes.  Photoinitiator was supplemented at 10 min 
to account for photolysis.  Reactions in DMF were precipitated in chilled diethyl ether and 
washed (2x) and then purified using RP-HPLC.  Reactions in H2O were diluted and directly 
purified with RP-HPLC. 
Evaluation of multivalent RGD peptides 
A competitive binding ELISA was used to determine the potency of the multivalent RGD 
peptides.  GPIIb/IIIa is known to contain the integrins !IIb and "3, which bind RGD peptide 
sequences.  Fibrinogen is also known to bind to these integrins.  The ELISA was performed to 
quantitate the inhibition of bound fibrinogen in the presence of RGD peptide.  The ELISA was 
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performed as described previously.
22
  Briefly, GPIIb/IIIa was incubated in a 96 well Maxisorp 
plate (Nunc) (10µg mL
-1
) overnight at 4°C.  The plate was blocked for non-specific interactions 
using BSA (3.5 wt%, 3hr).  Varying peptides concentrations and fibrinogen (40nM) was 
incubated in the plate for 3hr at room temperature.   Fibrinogen antibody (HRP) (1:20,000 
dilution) as added (1hr).  The substrate (2,2'-Azinobis [3-ethylbenzothiazoline-6-sulfonic acid]- 
diammonium salt-ABTS) was added and the absorbance measured at 405nm.  Peptide 
concentrations are reported as total molecule molarity as opposed to normalized [RGD]. 
6.4. Results and Discussion 
Our approach exploits the natural amino acid, cysteine, as the thiol source for sequential 
thiol-mediated photoreactions.  Linear (1) and cyclic (2) RGD were synthesized on the solid 
phase using MBHA Rink Amide resin.  2 was cyclized using thiol-ene photochemistry as 
described previously.
22
 Briefly, Fmoc-C(Mmt)RGDSfK(Alloc)-resin was synthesized.  The 
monomethoxytrityl (Mmt) was selectively deprotected on resin following an established 
protocol.  The thiol-ene reaction was performed in the presence of photoinitiator (2,2-dimethoxy-
2-phenylacetophenone: DMPA) and UV light (365nm, 20mW cm
-2
) for 3 hr.  Upon reaction 
completion, the Fmoc group was removed and Gly, Gly, Cys(Trt) were subsequently coupled in 
a step-wise manner.  2 was isolated in 15% yield (calculated based on initial resin substitution) 
and characterized by MALDI-TOF and 
1
H-NMR.   
 Various core molecules (n=1,2, or 3 where n indicates the number of alkynes) were 
prepared using traditional peptide chemistry.  4-Pentynoic acid was coupled to the !-amino 
groups of Lys amino acids to introduce alkynes orthogonal to the peptide backbone.  The thiol-
yne photoreaction is capable of achieving clustered peptides where the valency is equal to 2n.  
All thiol-yne reactions were performed using unprotected peptides in solution.  The reaction 
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solvent was chosen based on peptide solubility at the required concentrations (~0.2M).  1 and 2 
were used in water and dimethylformamide (DMF), respectively.  The appropriate photoinitiator 
was selected based on its solubility in the reaction solvent; LAP, lithium phenyl-2,4,6-
trimethylbenzoylphosphinate,
26
 was used for water while DMPA, 2,2-dimethoxy-2-phenyl 
acetophenone, was used with DMF. Table 6.1 shows the various multivalent RGD derivatives 
that were synthesized and their corresponding molecular weight.  Linear RGD derivatives (3 – 5) 
were obtained in very good yields.  Cyclic RGD multimers 6 and 7 were obtained in 48% and 
11% yield, respectively.  8 (cyclic RGD hexamer) was not observed.   
Table 6.1 Calculated yields of multivalent RGD derivatives. 
 
a
Compounds 1 and 2 correspond to linear H-CGGRGDS-NH2 and cyclic H-
CGGc[CRGDSfK(Alloc)]-NH2, respectively.  Formed via SPPS, isolated yields reported in 
Supporting Information.  
b
Type I initiators were chosen based on peptide solubility. 
We hypothesize the reason for decreased yields with increasing n relates to steric hindrances.  
The bulky macrocycles may prevent, or limit, the addition of 2 thiol containing peptides to 1 
alkyne.  During the formation of 7 the dominant product obtained contained 2 additions (as 
opposed to 4).  
1
H NMR shows the presence of vinyl protons (vinyl sulfide) indicating single 
peptide addition to each alkyne (as opposed to double peptide addition to 1 alkyne).  Although 
not explored in this contribution, this collective data indicates that increasing the spatial distance 
between alkynes or between the thiol and cyclic peptide may result in increased yield. 
Compound 
#
R n Initiatorb Calc. MW
[M+H]+ 
Found
Purified 
Yield (%)
1a 1 - - 649.7 650.6 -a
2a 2 - - 1111.3 1112.2 -a
3 1 1 LAP 1638.8 1639.8 84
4 1 2 LAP 3373.6 3374.8 87
5 1 3 LAP 5108.5 5110.1 77
6 2 1 DMPA 2561.9 2563.2 48
7 2 2 DMPA 5219.9 5222.5 11
8 2 3 DMPA 7877.9 - 0
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 Studies were then performed to investigate the kinetics of the thiol-yne photoreaction.  
The formation of 4 was used as a model system to explore the reaction rate. Figure 6.2 shows 
sequential HPLC chromatograms corresponding to various time points of the reaction.  The 
reaction is very rapid (~20min) and the desired product (4, peak A) was formed as the dominant 
peak. Peak C corresponds to a single peptide addition to a single alkyne as determined by 
1
H 
NMR (Supporting Information Figure S6.2). 
 
Figure 6.2 Evolution of 4 (Linear RGD tetramer) determined by RP-HPLC.  Peak A corresponds 
to desired product, Peak B to 3 additions, and Peak C to 2 additions. 
1 min 
2 min 
5 min 
10 min 
20 min 
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 To evaluate the bioactivity of multivalent RGD derivatives formed via thiol-yne 
photochemistry, a competitive binding ELISA was performed.  RGD has been shown to inhibit 
the binding of fibrinogen to GPIIb/IIIa.
27
  Table 6.2 shows the calculated IC50 values for 
compounds 1 – 7.  As expected, cyclic RGD (2) formed by thiol-ene reaction exhibited enhanced 
potency relative to linear RGD (1).  Further, 7 and 5 demonstrated a decreased IC50 value of 1.5-
2 orders of magnitude relative to their monomeric species. 
Table 6.2 IC50 values for multivalent RGD corresponding to inhibition of fibrinogen binding to 
GPIIb/IIIa. 
 
a
Values reported as mean ± SEM. Experiments were conducted in triplicate and repeated twice. 
6.5. Conclusion 
In summary, this Communication presents a novel strategy for the formation of multivalent 
peptides using thiol-yne photochemistry.  The reaction is very rapid (~20 min) and results in 
desired products obtained in relatively high yields for linear peptides (77-84%). Further, this 
work demonstrates that multiple thiol-mediated photoreactions (thiol-ene/thiol-yne) can be used 
sequentially to enhance peptide effects.  This report has implications in the field of peptide 
chemistry and its application to peptide therapeutics. 
Compound # R n IC50 (µM)
a
1 1 - 15.4 ± 4.2
2 2 - 0.65 ± 0.1
3 1 1 5.65 ± 1.5
4 1 2 2.42 ± 0.4
5 1 3 0.76 ± 0.2
6 2 1 0.14 ± 0.03
7 2 2 0.012 ± 0.003
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6.8. Supporting Information 
Kinetics of photoinitiated thiol-yne peptide clustering 
Model System: Core 2 + 1 to form 4 (Linear RGD tetramer).  
 
Figure S6.1 Relative amounts of varying species present during the thiol-yne induced formation 
of a linear RGD tetramer.  Determined by integration of the corresponding HPLC peaks. 
 
Figure S6.2
1
H NMR corresponding to Peak C in Figure 6.2.  Highlighted peaks (
1
H ! 6.02 – 
5.63 ppm) correspond to vinyl sulfide proton peaks. 
!
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7. Chapter 7 
Conclusions and Recommendations 
 
 PEG-based hydrogels represent a class of biomaterials with a growing interest for their 
application in numerous fields, such as drug delivery and regenerative medicine.  PEG is 
commonly used in these applications due to its hydrophilic and inert properties.  However, 
bioinert materials that present blank slates cannot provide the necessary biological cues needed 
for applications in cell delivery, to promote survival and differentiation, nor are these materials 
capable of adapting/responding to local environmental stimuli.  As a result, peptides have been 
successfully incorporated within PEG hydrogels to serve as recognized biomolecules within a 
synthetic polymer platform.  Peptides have been shown to act as ECM-mimics capable of 
enhancing cell survival, function, and differentiation within peptide-functionalized PEG 
hydrogels.  Alternatively, peptides can be designed to degrade in recognition of highly specific, 
cell-secreted proteases.  This phenomenon has been exploited for the fabrication of peptide-
functionalized hydrogels capable of undergoing macroscopic property changes in response to 
cellular events.  The goal of this thesis work was to design functional peptide sequences and 
control their presentation within PEG hydrogels for various biological applications.  Specifically, 
peptides were engineered to respond to cellular stimuli and enhance integrin binding when 
incorporated within PEG hydrogels. 
 First, we aimed to design peptides that would degrade in response to an enzyme that is 
up-regulated during inflammation.  When incorporated within PEG hydrogels, these peptides 
would degrade in response to a selected protease and allow for subsequent therapeutic release.  
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Human neutrophil elastase (HNE) is an enzyme secreted by activated neutrophils, which are first 
responders to inflammatory sites.  This protease was targeted as a suitable enzyme trigger 
capable of initiating drug release from hydrogel platforms.   
Initially, peptides were engineered to degrade in response to HNE allowing for cell-
dictated therapeutic release from hydrogel platforms (Chapter 3).  Amino acid point mutations 
within the HNE substrate and the effects on enzyme-mediated degradation were investigated.  
Specifically, amino acids in the P1 and P1’ positions were varied and a solution-phase enzyme 
assay allowed for quantification of Michaelis-Menten constants. Positively charged arginine and 
short aliphatic amino acids in the P1’ and P1 positions, respectively, resulted in a substrate with 
enhanced enzyme kinetic constants.  Deviations from this scenario resulted in peptides exhibiting 
decreased kinetic constants, ultimately illustrating tailorable control over the rate of enzyme-
mediated substrate degradation.  Additionally, peptides were acrylated using a heterobifunctioal 
PEG linker and subsequently photopolymerized within hydrogels.  A FRET-based HNE 
substrate was designed to allow for spatial visualization of enzyme activity within the 
macroscopic gel.  This was critical to ensure sufficient accessibility of the substrate to the 
enzyme within a highly crosslinked hydrogel system.  HNE was capable of diffusing to all 
locations within the gel and was confirmed using microscopy techniques.  Additionally, enzyme-
mediated release from hydrogel systems was demonstrated, and the rate was found to be 
dependent on substrate and enzyme concentration.  A diffusion-reaction kinetic model was 
developed as a method to characterize the release from hydrogel platforms.  Fickian diffusion 
and Michaelis-Menten enzyme kinetics were implemented to describe the diffusion and reaction 
components of the system, respectively.   Although not explored in this work, conjugation of a 
relevant small molecule anti-inflammatory therapeutic to the HNE substrate would provide true 
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validation of this system.  Since covalent modification of the drug would be required, it is 
essential to test the efficacy of the therapeutic for its intended application. Lisofylline, 
ketoprofen, and D-penicillamine are potential small molecule anti-inflammatory drugs that are of 
specific interest due to the presence of modifiable functional groups, as well as their therapeutic 
mechanism of action.  Additionally, HNE was added exogenously to characterize the developed 
hydrogel drug delivery system.  Using cell-secreted HNE to trigger release of an anti-
inflammatory therapeutic and assaying for a specific cell response would provide a system that 
more closely mimics the in vivo environment allowing for a more thorough evaluation of this 
platform. 
 Next, developed HNE substrates were incorporated as functional crosslinks within PEG-
based hydrogels rendering the network degradable upon exposure to HNE (Chapter 4).  Thiol-
ene photopolymerization provided a facile means for peptide incorporation.  A 4-arm PEG was 
functionalized with norbornene moieties, and a bis-cysteine HNE substrate was synthesized.  
When combined together with a photoinitiator and light source, these monomers form a nearly 
ideal, crosslinked hydrogel via a step-growth reaction mechanism.  Gelation was found to occur 
within the first minute of UV light exposure under specified conditions.  Hydrogel mass loss 
studies provided insight as to the mechanism and kinetics of the enzyme-triggered degradation.  
Constant equilibrium swelling ratios as a function of degradation indicated a surface erosion 
mechanism for a wide range of conditions.  Additionally, increasing kcat of the substrate resulted 
in an increased rate of gel mass loss, and increasing the enzyme concentration or decreasing the 
substrate concentration enhanced the rate of gel degradation.  Next, proteins were included in the 
prepolymer solution and physically entrapped upon gel formation.  In the presence of HNE, the 
rate of protein release was directly correlated to the rate of gel degradation.   Different proteins, 
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of varying sizes, exhibited similar release profiles, which were solely determined by the gel 
formulation.  Additionally, a 3-layered hydrogel system, containing different gel formulations in 
each layer was formed by sequential photopolymerizations.  A predictable bimodal release 
profile and the ability to tailor the release of multiple proteins were achieved.  To significantly 
advance this work, a cell-based, in vitro assay to evaluate the utility of this device is needed.  
Additionally, encapsulation of a more clinically relevant protein, such as the anti-inflammatory 
interleukin 1 receptor antagonist (IL-1ra), could be used in an in vivo disease model where 
inflammation is implicated.  For example, rheumatoid arthritis is a debilitating disease caused by 
chronic inflammation.  IL-1ra is one current treatment for patients with this condition.   
However, like most proteins, IL-1ra has a short circulation time in vivo and requires multiple 
administrations to sustain a therapeutic concentration.  Encapsulating the protein in a drug 
delivery vehicle protects the therapeutic from undesirable degradation.  Use of a PEG-based drug 
delivery hydrogel developed herein would serve as a method to achieve controlled, cellularly 
responsive release in recognition of an inflammatory event.  
 Objective 3 focused on the design and synthesis of cyclic, multivalent peptides using 
photoinitiated, radical-mediated chemistries.  First, we developed a novel method to form cyclic 
peptides on-resin using thiol-ene chemistry.  Naturally occurring cysteine amino acids were used 
as the thiol source while various alkenes were incorporated orthogonal to the peptide backbone.  
The use of a commercially available alkene amino acid, allyloxycarbonyl (Alloc), and one that 
required post-synthetic modification, norbornene, were explored in this thesis.  Additionally, 
various reaction initiation schemes were studied.  Photoinitiated radical generation resulted in a 
more rapid reaction with a higher recovered yield relative to thermal initiation, and conducting 
the reaction on-resin proved advantageous due to the pseudodilution effect and ease of 
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purification.  As demonstrated in literature, the reaction using a strained, bicyclic alkene 
(norbornene) was more rapid than the allyloxycarbonyl group due to its increased reactivity.  
Extensive analytical characterization techniques were used to confirm the identity of each cyclic 
product.  A ubiquitous cell adhesion ligand, RGD, was used as a model peptide to demonstrate 
the use of this reaction for cyclic peptide formation.  To confirm the therapeutic efficacy of the 
product, a solid-phase binding ELISA was used.  Cyclic RGD formed by thiol-ene chemistry was 
found to prevent fibrinogen binding to glycoprotein IIb/IIIa at low micromolar concentrations.  
Linear RGD was found to be an order of magnitude less potent at preventing binding as 
expected.   
 Next, we aimed to utilize a thiol-yne reaction as a facile method to form multivalent 
peptides.  Recently, the photoinitiated thiol-yne reaction was presented in literature as a radical-
mediated reaction between two thiols and one alkyne.  Thiol-containing peptides were added to 
alkyne-containing peptidomimetics in solution and irradiated with UV light.  The valency of the 
product was found to be twice the number of alkynes present per molecule.  Further, the reaction 
was found to be relatively rapid (<20 minutes) and resulted in multivalent linear peptides in 
increased yield relative to multivalent cyclic peptides.  Similarly, the therapeutic potency of the 
multivalent products was evaluated as before.  Tetrameric, cyclic RGD exhibited decreased IC50 
values (12 nM) relative to the monomeric, cyclic form (650 nM). 
 Although not presented thus far within the thesis, initial studies using the cyclic RGD 
derivatives formed in Objective 3 were evaluated for their ability to promote MIN6 viability 
within peptide-functionalized PEG hydrogel.  Further, we examined the potential to exploit the 
spatial control of the photoreactions to pattern thiol-containing peptides within PEG hydrogels 
displaying pendant alkenes or alkynes.  These experiments provide a foundation for future work 
 132 
to be explored controlling peptide presentation within hydrogels using thiol-ene/thiol-yne 
photoreactions.   
 The viability of encapsulated MIN6 cells, a murine pancreatic !-cell line, is known to be 
low when encapsulated in synthetic hydrogels at a low density.  Increased cell density has shown 
some success in promoting long-term survival due to cell-cell contact, but leads to other 
complications.  Further, covalent conjugation of ECM-like molecules, especially linear peptides, 
within PEG hydrogels has also been demonstrated to increase cell viability.
1,2
  We hypothesized 
that incorporating cyclic RGD, a fibronectin mimic that retains structural similarity to the intact 
protein, might further enhance the survival of MIN6 cells when encapsulated in PEG gels at 
relatively low cell densities.  In Chapter 5, we described a novel method to form cyclic RGD on-
resin using thiol-ene photochemistry.  However, this molecule did not contain suitable functional 
groups available for covalent incorporation within PEG networks during photopolymerization.  
We extended this work to synthesize cyclic RGD on-resin that contained a free thiol that could 
be utilized for conjugation into PEG networks via thiol-acrylate photopolymerizations.  
Additionally, we were interested in understanding if multivalent, cyclic RGD further enhanced 
cell survival due to natural clustering to cell surface integrins that RGD is known to bind.  To 
test these hypotheses, a cyclic RGD dimer was synthesized and thiolated using Traut’s reagent. 
Figure 7.1 illustrates the synthetic routes taken to form the desired cyclic RGD products.  
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Figure 7.1 (a) Synthetic route to form cyclic RGD containing a free thiol.  Conditions: (i) Thiol-
ene photoreaction to form cyclic peptide. (ii) Deprotect Fmoc. (iii) Couple glycine, glycine, 
cysteine using standing coupling chemistries. (iv) Deprotect/cleave peptide from resin.  (b) 
Synthetic route to form cyclic RGD dimer containing a free thiol. 
To examine whether the cyclic RGD derivatives would enhance cell viability, MIN6 cells 
were encapsulated at a relatively low density (5 x 10
6
 cells mL
-1
, data not published) in PEG 
diacrylate gels with varying amounts of RGD.  Cell metabolic activity was measured using an 
Alamar Blue assay. Figure 7.2a shows initial dosing studies using either linear or cyclic RGD on 
MIN6 metabolic activity.  Cyclic RGD (400 µM) showed significantly enhanced metabolic 
activity relative to its linear counterpart at the same concentration.  Additionally, incorporation 
of 100 µM cyclic RGD resulted in increased viability, whereas 100 µM linear RGD was not able 
to support cell survival over the course of the 10-day study.  Further, cells encapsulated in 
hydrogels containing the cyclic RGD dimer showed enhanced metabolic activity relative to the 
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monomeric product (Figure 7.2b).  Total molar RGD concentration was held constant during the 
study.   
 
Figure 7.2 Incorporation of cyclic and linear RGD within PEG hydrogels and its effect on 
encapsulated MIN6 cell metabolic activity. (a) RGD effect at various concentrations and 
conformations.  (b) Clustered RGD effect. *In collaboration with Chien-Chi Lin. 
Future recommendations include utilizing photopatterning techniques to understand cell 
behavior when ECM mimic peptides are incorporated within spatially defined regions.  Further, 
Weber et al. demonstrated enhanced MIN6 cell viability when encapsulated within hydrogels 
functionalized with matrix-derived adhesive peptides.
2
  In specific, laminin-derived peptide 
sequences (IKLLI, IKVAV, LRE, PDSGR, RGD, and YIGSR) were photopolymerized within 
PEG hydrogels and cell viability and insulin secretion were assayed.  The results proved cell 
viability was increased within peptide-functionalized hydrogels.  Also, inclusion of multiple 
peptides provided insight to the synergistic effects.  Since these sequences were all derived from 
a whole intact protein, laminin, it is reasonable to hypothesize that constraining the conformation 
using macrocyclization techniques would further enhance their effect on !-cell viability. 
Additionally, since cells encapsulated within PEG hydrogels are surrounded in a synthetic 
environment, it is important to study the effect of ECM-derived peptide presentation 
(cyclic/multivalent) on multiple cell functions and cell types.   
! " 
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 Initial studies were undertaken to illustrate how the thiol-yne photoreaction can provide a 
facile method to pattern clustered adhesive peptides (RGD) on and within PEG hydrogels.  
Maheshwari et al.
3
 demonstrated the importance of nanoscale RGD clustering on cell adhesion 
and motility.  We hypothesized use of sequential thiol-ene/thiol-yne photoreactions would 
provide a robust and efficient way to control the presentation of peptides within biomaterials.  To 
test this claim, PEG hydrogels were formed using strain promoted azide alkyne cycloaddition 
(SPAAC) using 4-arm PEG functionalized with difluorinated cyclooctyne (DIFO3) and a bis-
azide peptide.  The peptide was designed to contain either an alkene or alkyne functional group 
orthogonal to the peptide background.  The synthetic route for gel formulation is depicted in 
Figure 7.3. 
 
Figure 7.3 Hydrogel formation using SPAAC.  Various peptides were combined with 4-arm 
PEG-DIFO3 to fabricate hydrogels with pendant alkenes or alkynes. *In collaboration with Cole 
DeForest. 
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 DeForest et al. performed extensive studies to characterize the thiol-ene patterning of 
cysteine containing peptides with the allyl ester functional group in similar hydrogel platforms.
4
  
We then aimed to demonstrate the feasibility of using the thiol-yne photoreaction as a method to 
achieve spatially controlled peptide patterning (Figure 7.4a).  Initially, PEG gels formed using 
SPACC with pendant alkynes were swollen in a fluorescent peptide solution (Alexa Fluor® 488-
Ahx-RGDSC-NH2; 3mg mL
-1
) containing photoinitiator (I-2959; 4-(2-hydroxyethoxy)phenyl-(2-
hydroxy-2-propyl)ketone; 0.05wt%) for 2 hrs.  Gels were then exposed to UV light (365 nm, 10 
mW cm
-2
, 5 min) through a photomask to selectively pattern regions of the hydrogel.  The gel 
was then placed in fresh PBS overnight to allow unreacted peptide to diffuse away.  The pattern 
was imaged using confocal microscopy.  Further, an initial study was performed to examine the 
concentration of RGD patterning as a function of light exposure time within hydrogels 
functionalized with pendant alkenes and alkynes (Figure 7.4b). 
 
Figure 7.4 (a) Thiol-yne photopatterning of fluorescent H-Ahx-RGDSC-NH2.  Scale 
bar=100µm. (b) Concentration of patterned RGD as a function of reaction time within gels 
functionalized with pendant alkenes and alkynes. 
Extensive work is needed to characterize peptide patterning using thiol-yne 
photoreactions.  For example, the kinetics and degree of patterning needs to further be examined, 
a b 
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as well as provide evidence that the subsequent thiol-vinyl sulfide reaction occurs.  After 
characterization, cell studies are needed to determine if the nanoscale clustering of RGD using 
this method can influence cell behavior (i.e. adhesion and/or migration).  If successful, this 
technology can then be applied to 3-dimensional cell culture to further study cell-matrix 
interactions. 
Collectively, the work presented in this thesis aimed to exploit the versatility of peptides 
and the synthetic advantages of controlling their presentation within hydrogels using 
photoreactions.  This research provides insight on peptide design and subsequent use within 
synthetic hydrogels for various biological applications such has drug delivery and regenerative 
medicine. 
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